Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury

Cell Transplantation

Volumn 22, Issue 4, 2013, Pages 571-617

  Kramer, Anne S ^a   Harvey, Alan R ^a   Plant, Giles W ^b   Hodgetts, Stuart I ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Induced pluripotency; Regeneration; Replacement; Spinal cord; Stem cell therapy; Trophic support

Indexed keywords

BMI1 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; KRUPPEL LIKE FACTOR 4; MICRORNA; MITOCHONDRIAL DNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SOX7; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; DEMYELINATION; DNA METHYLATION; EMBRYONIC STEM CELL; EX VIVO GENE TRANSFER; EXCITOTOXICITY; GENE EXPRESSION; HUMAN; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; LIPID PEROXIDATION; MOLECULAR CLONING; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SCAR; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; SYSTEMATIC REVIEW (TOPIC);

ANIMALS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NERVE REGENERATION; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION;

EID: 84876468115     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X655208     Document Type: Review

References (428)

1. Aasen, T.; Izpisua Belmonte, J. C. Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat. Protoc. 5:371-382; 2010.
2. Aasen, T.; Raya, A.; Barrero, M. J.; Garreta, E.; Consiglio, A.; Gonzalez, F.; Vassena, R.; Bilic, J.; Pekarik, V.; Tiscornia, G.; Edel, M.; Boue, S.; Izpisua Belmonte, J. C. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26:1276-1284; 2008.
3. Abdullah, Z.; Saric, T.; Kashkar, H.; Baschuk, N.; Yazdanpanah, B.; Fleischmann, B. K.; Hescheler, J.; Kronke, M.; Utermohlen, O. Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTL. J. Immunol. 178:3390-3399; 2007.
4. Abe, Y.; Yamamoto, T.; Sugiyama, Y.; Watanabe, T.; Saito, N.; Kayama, H.; Kumagai, T. Apoptotic cells associated with wallerian degeneration after experimental spinal cord injury: A possible mechanism of oligodendroglial death. J. Neurotrauma 16:945-952; 1999.
5. Agarwal, S.; Loh, Y.-H.; McLoughlin, E. M.; Huang, J.; Park, I.-H.; Miller, J. D.; Huo, H.; Okuka, M.; dos Reis, R. M.; Loewer, S.; Ng, H.-H.; Keefe, D. L.; Goldman, F. D.; Klingelhutz, A. J.; Liu, L.; Daley, G. Q. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464:292-298; 2010.
6. Akesson, E.; Wolmer-Solberg, N.; Cederarv, M.; Falci, S.; Odeberg, J. Human neural stem cells and astrocytes, but not neurons, suppress an allogeneic lymphocyte response. Stem Cell Res. 2:56-67; 2009.
7. Alipio, Z.; Liao, W.; Roemer, E. J.; Waner, M.; Fink, L. M.; Ward, D. C.; Ma, Y. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)- derived pancreatic p-like cells. Proc. Natl. Acad. Sci. USA 107:13426-13431; 2010.
8. Anokye-Danso, F.; Trivedi, C. M.; Juhr, D.; Gupta, M.; Cui, Z.; Tian, Y.; Zhang, Y.; Yang, W.; Gruber, P. J.; Epstein, J. A.; Morrisey, E. E. Highly efficient miRNA- mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8:376-388; 2011.
9. Apostolova, I.; Irintchev, A.; Schachner, M. Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice. J. Neurosci. 26:7849-7859; 2006.
10. Araki, R.; Hoki, Y.; Uda, M.; Nakamura, M.; Jincho, Y.; Tamura, C.; Sunayama, M.; Ando, S.; Sugiura, M.; Yoshida, M. A.; Kasama, Y.; Abe, M. Crucial role of c-myc in the generation of induced pluripotent stem cells. Stem Cells 29:1362-1370; 2011.
11. Armstrong, L.; Tilgner, K.; Saretzki, G.; Atkinson, S.; Stojkovic, M.; Moreno, R.; Przyborski, S.; Lako, M. Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells 28:661-673; 2010.
12. Arnhold, S.; Klein, H.; Semkova, I.; Addicks, K.; Schraermeyer, U. Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest. Opthalmol. Vis. Sci. 45:4251-4255; 2004.
13. Asher, R. A.; Morgenstern, D. A.; Moon, L. D. F.; Fawcett, J. W. Chondroitin sulphate proteoglycans: Inhibitory components of the glial scar. Prog. Brain Res. 132:611-619; 2001.
14. Baker, D. E. C.; Harrison, N. J.; Maltby, E.; Smith, K.; Moore, H. D.; Shaw, P. J.; Heath, P. R.; Holden, H.; Andrews, P. W. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 25:207-215; 2007.
15. Ban, H.; Nishishita, N.; Fusaki, N.; Tabata, T.; Saeki, K.; Shikamura, M.; Takada, N.; Inoue, M.; Hasegawa, M.; Kawamata, S.; Nishikawa, S.-I. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc. Natl. Acad. Sci. USA 108:14234-14239; 2011.
16. Banito, A.; Rashid, S. T.; Acosta, J. C.; Li, S.; Pereira, C. F.; Geti, I.; Pinho, S.; Silva, J. C.; Azuara, V.; Walsh, M.; Vallier, L.; Gil, J. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 23:2134-2139; 2009.
17. Bareyre, F.; Kerschensteiner, M.; Raineteau, O.; Mettenleiter, T.; Weinmann, O.; Schwab, M. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat. Neurosci. 7:269-277; 2004.
18. Bar-Nur, O.; Russ, H. A.; Efrat, S.; Benvenisty, N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet β-cells. Cell Stem Cell 9:17-23; 2011.
19. Basso, D.; Beattie, M.; Bresnahan, J. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139:244-256; 1996.
20. Becerra, J. L.; Puckett, W. R.; Hiester, E. D.; Quencer, R. M.; Marcillo, A. E.; Post, M. J. D.; Bunge, R. P. MR-Pathological comparisons of Wallerian degeneration in spinal cord injury. Am. J. Neuroradiol. 16:125-133; 1995.
21. Behfar, A.; Perez-Terzic, C.; Faustino, R. S.; Arrell, D. K.; Hodgson, D. M.; Yamada, S.; Puceat, M.; Niederlander, N.; Alekseev, A. E.; Zingman, L. V.; Terzic, A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J. Exp. Med. 204:405-20; 2007.
22. Ben-David, U.; Benvenisty, N. High prevalence of evolution- arily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells 30:612-622; 2012.
23. Ben-David, U.; Benvenisty, N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 11:268-277; 2011.
24. Ben-Nun, I. F.; Montague, S. C.; Houck, M. L.; Tran, H. T.; Garitaonandia, I.; Leonardo, T. R.; Wang, Y.-C.; Charter, S. J.; Laurent, L. C.; Ryder, O. A.; Loring, J. F. Induced pluripotent stem cells from highly endangered species. Nat. Methods 8:829-831; 2011.
25. Bilousova, G.; Jun, D. H.; King, K. B.; De Langhe, S.; Chick, W. S.; Torchia, E. C.; Chow, K. S.; Klemm, D. J.; Roop, D. R.; Majka, S. M. Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells 29:206-216; 2011.
26. Blelloch, R.; Venere, M.; Yen, J.; Ramalho-Santos, M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 1:245-247; 2007.
27. Blight, A. Cellular morphology of chronic spinal cord injury in the cat: Analysis of myelinated axons by line- sampling. Neurosci. 10:521-543; 1983.
28. Blin, G.; Nury, D.; Stefanovic, S.; Neri, T.; Guillevic, O.; Brinon, B.; Bellamy, V.; Ruecker-Martin, C.; Barbry, P.; Bel, A.; Bruneval, P.; Cowan, C.; Pouly, J.; Mitalipov, S.; Gouadon, E.; Binder, P.; Hagege, A.; Desnos, M.; Renaud, J.-F.; Menasche, P.; Puceat, M. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J. Clin. Invest. 120:1125-1139; 2010.
29. Blum, B.; Benvenisty, N. The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 8:3822-3830; 2009.
30. Boland, M. J.; Hazen, J. L.; Nazor, K. L.; Rodriguez, A. R.; Gifford, W.; Martin, G.; Kupriyanov, S.; Baldwin, K. K. Adult mice generated from induced pluripotent stem cells. Nature 461:91-96; 2009.
31. Bonde, S.; Zavazava, N. Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 24:2192-2201; 2006.
32. Bonnamain, V.; Neveu, I.; Naveilhan, P. Neural stem/ progenitor cells as a promising candidate for regenerative therapy of the central nervous system. Front. Cell. Neurosci. 6:1-8; 2012.
33. Bonner, J.; Blesch, A.; Neuhuber, B.; Fischer, I. Promoting direcftional axon growth from neural progenitors grafterd into the injured spinal cord. J. Neurosci. Res. 88:1182-1192; 2009.
34. Bosio, E.; Lee-Pullen, T. F.; Fragall, C. T.; Beilharz, M. W.; Bennett, A. L.; Grounds, M. D.; Hodgetts, S. I.; Sammels, L. M. A comparison between real-time quantitative PCR and DNA hybridization for quantitation of male DNA following myoblast transplantation. Cell Transplant. 13:817-821; 2004.
35. Boulting, G. L.; Kiskinis, E.; Croft, G. F.; Amoroso, M. W.; Oakley, D. H.; Wainger, B. J.; Williams, D. J.; Kahler, D. J.; Yamaki, M.; Davidow, L.; Rodolfa, C. T.; Dimos, J. T.; Mikkilineni, S.; MacDermott, A. B.; Woolf, C. J.; Henderson, C. E.; Wichterle, H.; Eggan, K. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 29:279-286; 2011.
36. Bouzier-Sore, A. K.; Merle, M.; Magistretti, P. J.; Pellerin, L. Feeding active neurons: (Re)emergence of a nursing role for astrocytes. J. Physiol. Paris 96:273-282; 2002.
37. Boyd, A. S.; Fairchild, P. J. Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies. Expert Rev. Clin. Immunol. 6:435-448; 2010.
38. Boyd, A. S.; Rodrigues, N. P.; Lui, K. O.; Fu, X.; Xu, Y. Concise review: Immune recognition of induced pluripo- tent stem cells. Stem Cells 30:797-803; 2012.
39. Boyer, L. A.; Lee, T. I.; Cole, M. F.; Johnstone, S. E.; Levine, S. S.; Zucker, J. R.; Guenther, M. G.; Kumar, R. M.; Murray, H. L.; Jenner, R. G.; Gifford, D. K.; Melton, D. A.; Jaenisch, R.; Young, R. A. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956; 2005.
40. Brambrink, T.; Foreman, R.; Welstead, G. G.; Lengner, C. J.; Wernig, M.; Suh, H.; Jaenisch, R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2:151-159; 2008.
41. Bramlett, H. M.; Dietrich, W. D. Progressive damage after brain and spinal cord injury: Pathomechanisms and treatment strategies. Prog. Brain Res. 161:125-141; 2007.
42. Brennand, K. J.; Simone, A.; Jou, J.; Gelboin-Burkhart, C.; Tran, N.; Sangar, S.; Li, Y.; Mu, Y.; Chen, G.; Yu, D.; McCarthy, S.; Sebat, J.; Gage, F. H. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221-227; 2011.
43. Bresnahan, J. C. An electron-microscopic analysis of axonal alterations following blunt contusion of the spinal cord of the rhesus monkey (Macaca mulatta). J. Neurol. Sci. 37:59-82; 1978.
44. Brown, M. T. Moral complicity in induced pluripotent stem cell research. Kennedy Inst. Ethics J. 19:1-22; 2009.
45. Bruce, J. H.; Norenberg, M. D.; Kraydieh, S.; Puckett, W.; Marcillo, A.; Dietrich, D. Schwannosis: Role of gliosis and proteoglycan in human spinal cord injury. J. Neurotrauma 17:781-788; 2000.
46. Bullock, R.; Maxwell, W. L.; Graham, D. I.; Teasdale, G. M.; Adams, J. H. Glial swelling following human cerebral contusion: An ultrastructural study. J. Neurol. Neurosurg. Psychiatry 54:427-434; 1991.
47. Bunge, R. P.; Puckett, W.; Becerra, J. L.; Marcillo, A.; Quencer, R. M. Observations on the pathology of human spinal cord injury: A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 59:75-89; 1993.
48. Buss, A.; Brook, G. A.; Kakulas, B.; Martin, D.; Franzen, R.; Schoenen, J.; Noth, J.; Schmitt, A. B. Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain 127:34-44; 2004.
49. Cai, J.; Yang, M.; Poremsky, E.; Kidd, S.; Schneider, J. S.; Iacovitti, L. Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev. 19:1017-1023; 2010.
50. Cao, F.; Drukker, M.; Lin, S.; Sheikh, A. Y.; Xie, X.; Li, Z.; Connolly, A. J.; Weissman, I. L.; Wu, J. C. Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. Cloning Stem Cells 9:107-117; 2007.
51. Cao, F.; Lin, S.; Xie, X. Y.; Ray, P.; Patel, M.; Zhang, X. Z.; Drukker, M.; Dylla, S. J.; Connolly, A. J.; Chen, X. Y.; Weissman, I. L.; Gambhir, S. S.; Wu, J. C. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113:1005-1014; 2006.
52. Cao, Q.; Howard, R.; Dennison, J.; Whittemore, S. Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Exp. Neurol. 177:349-359; 2002.
53. Carey, B. W.; Markoulaki, S.; Hanna, J.; Saha, K.; Gao, Q.; Mitalipova, M.; Jaenisch, R. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl. Acad. Sci. USA 106:157-162; 2009.
54. Carey, B. W.; Markoulaki, S.; Hanna, J. H.; Faddah, D. A.; Buganim, Y.; Kim, J.; Ganz, K.; Steine, E. J.; Cassady, J. P.; Creyghton, M. P.; Welstead, G. G.; Gao, Q.; Jaenisch, R. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluri- potent stem cells. Cell Stem Cell 9:588-598; 2011.
55. Carlson, S. L.; Parrish, M. E.; Springer, J. E.; Doty, K.; Dossett, L. Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 151:77-88; 1998.
56. Carpenter, L.; Carr, C.; Yang, C. T.; Stuckey, D. J.; Clarke, K.; Watt, S. M. Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. Stem Cells Dev. 21:977-986; 2012.
57. Chamberlain, S. J.; Chen, P. F.; Ng, K. Y.; Bourgois-Rocha, F.; Lemtiri-Chlieh, F.; Levine, E. S.; Lalande, M. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc. Natl. Acad. Sci. USA 107:17668-17673; 2010.
58. Chambers, S. M.; Fasano, C. A.; Papapetrou, E. P.; Tomishima, M.; Sadelain, M.; Studer, L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27:275-280; 2009.
59. Chan, A. W. S.; Cheng, P.-H.; Neumann, A.; Yang, J.-J. Reprogramming Huntington monkey skin cells into pluri- potent stem cells. Cell. Reprogram. 12:509-517; 2010.
60. Chan, E. M.; Ratanasirintrawoot, S.; Park, I.-H.; Manos, P. D.; Loh, Y.-H.; Huo, H.; Miller, J. D.; Hartung, O.; Rho, J.; Ince, T. A.; Daley, G. Q.; Schlaeger, T. M. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 27:1033-1037; 2009.
61. Chang, C.-W.; Lai, Y.-S.; Pawlik, K. M.; Liu, K.; Sun, C. -W.; Li, C.; Schoeb, T. R.; Townes, T. M. Polcystronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 27:1042-1049; 2009.
62. Chang, T.; Zheng, W.; Tsark, W.; Bates, S.; Huang, H.; Lin, R. J.; Yee, J. K. Brief report: Phenotypic rescue of induced pluripotent stem cell-derived motorneurons of a spinal muscular atrophy patient. Stem Cells 29:2090-2093; 2011.
63. Chaudhry, G. R.; Fecek, C.; Lai, M. M.; Wu, W. C.; Chang, M.; Vasquez, A.; Pasierb, M.; Trese, M. T. Fate of embryonic stem cell derivatives implanted into the vitreous of a slow retinal degenerative mouse model. Stem Cells Dev. 18:247-258; 2009.
64. Chen, L.; Daley, G. Q. Molecular basis of pluripotency. Hum. Mol. Genet. 17:R23-R27; 2008.
65. Chen, L.; Liu, L. Current progress and prospects of induced pluripotent stem cells. Sci. China C. Life Sci. 52:622-636; 2009.
66. Chen, S.-J.; Chang, C.-M.; Tsai, S.-K.; Chang, Y.-L.; Chou, S.-J.; Huang, S.-S.; Tai, L.-K.; Chen, Y.-C.; Ku, H.-H.; Li, H.-Y.; Chiou, S.-H. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev. 19:1757-1767; 2010.
67. Chen, X.; Xu, H.; Yuan, P.; Fang, F.; Huss, M.; Vega, V. B.; Wong, E.; Orlov, Y. L.; Zhang, W.; Jiang, J.; Loh, Y.-H.; Yeo, H. C.; Yeo, Z. X.; Narang, V.; Govindarajan, K. R.; Leong, B.; Shahab, A.; Ruan, Y.; Bourque, G.; Sung, W.-K.; Clarke, N. D.; Wei, C.-L.; Ng, H.-H. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133:1106-1117; 2008.
68. Cheng, F.; Ke, Q.; Chen, F.; Cai, B.; Gao, Y.; Ye, C.; Wang, D.; Zhang, L.; Lahn, B. T.; Li, W.; Xiang, A. P. Protecting against wayward human induced pluripotent stem cells with a suicide gene. Biomaterials 33:3195-3204; 2012.
69. Cheng, L.; Hansen, N. F.; Zhao, L.; Du, Y.; Zou, C.; Donovan, F. X.; Chou, B.-K.; Zhou, G.; Li, S.; Dowey, S. N.; Ye, Z.; Chandrasekharappa, S. C.; Yang, H.; Mullikin, J. C.; Liu, P. P.; Progra, N. C. S. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 10:337-344; 2012.
70. Cheung, A. Y. L.; Horvath, L. M.; Grafodatskaya, D.; Pasceri, P.; Weksberg, R.; Hotta, A.; Carrel, L.; Ellis, J. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum. Mol. Genet. 20:2103-2115; 2011.
71. Chiang, C.-H.; Chang, C.-C.; Huang, H.-C.; Chen, Y.-J.; Tsai, P.-H.; Jeng, S.-Y.; Hung, S.-I.; Hsieh, J.-H.; Huang, H.-S.; Chiou, S.-H.; Lee, F.-Y.; Lee, S.-D. Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury. J. Biomed. Biotechnol. 2011:219060; 2011.
72. Chiang, C. H.; Su, Y.; Wen, Z.; Yoritomo, N.; Ross, C. A.; Margolis, R. L.; Song, H.; Ming, G. I. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol. Psych. 16:358-360; 2011.
73. Chin, M. H.; Mason, M. J.; Xie, W.; Volinia, S.; Singer, M.; Peterson, C.; Ambartsumyan, G.; Aimiuwu, O.; Richter, L.; Zhang, J.; Khvorostov, I.; Ott, V.; Grunstein, M.; Lavon, N.; Benvenisty, N.; Croce, C. M.; Clark, A. T.; Baxter, T.; Pyle, A. D.; Teitell, M. A.; Pelegrini, M.; Plath, K.; Lowry, W. E. Induced pluripotent stem cells and embryonig stem cells are distinguised by gene expression signatures. Cell Stem Cell 5:111-123; 2009.
74. Chin, M. H.; Pellegrini, M.; Plath, K.; Lowry, W. E. Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 7:263-269; 2010.
75. Chiou, S.-H.; Yu, C.-C.; Huang, C.-Y.; Lin, S.-C.; Liu, C. -J.; Tsai, T.-H.; Chou, S.-H.; Chien, C.-S.; Ku, H.-H.; Lo, J.-F. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 14:4085-4095; 2008.
76. Cho, H.-J.; Lee, C.-S.; Kwon, Y.-W.; Paek, J. S.; Lee, S.-H.; Hur, J.; Lee, E. J.; Roh, T.-Y.; Chu, I.-S.; Leem, S.-H.; Kim, Y.; Kang, H.-J.; Park, Y.-B.; Kim, H.-S. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 116:386-395; 2010.
77. Choi, S. M.; Kim, Y.; Liu, H.; Chaudhari, P.; Ye, Z.; Jang, Y.-Y. Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells. Cell Cycle 10:2423-2427; 2011.
78. Christodoulou, C.; Longmire, T. A.; Shen, S. S.; Bourdon, A.; Sommer, C. A.; Gadue, P.; Spira, A.; Gouon-Evans, V.; Murphy, G. J.; Mostoslavsky, G.; Kotton, D. N. Mouse ES and iPS cells can form similar definitive endoderm despite differences in imprinted genes. J. Clin. Invest. 121:2313-2325; 2011.
79. Chung, H. C. Y.; Lin, R. C. Y.; Logan, G. J.; Alexander, I. E.; Sachdev, P. S.; Sidhu, K. S. Human induced pluripotent stem cells derived under feeder-free conditions display unique cell cycle and DNA replication gene profiles. Stem Cells Dev. 21:206-216; 2012.
80. Cloutier, F.; Siegenthaler, M.; Nistor, G.; Keirstead, H. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regen. Med. 1:469-479; 2006.
81. Condic, M.; Letourneau, P. Ligand-induced changes in integrin expression regulate neuronal adhesion and neurite outgrowth. Nature 389:852-856; 1997.
82. Cooper, O.; Hargus, G.; Deleidi, M.; Blak, A.; Osborn, T.; Marlow, E.; Lee, K.; Levy, A.; Perez-Torres, E.; Yow, A.; Isacson, O. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol. Cell. Neurosci. 45:258-266; 2010.
83. Crowe, M. J.; Bresnahan, J. C.; Shuman, S. L.; Masters, J. N.; Beattie, M. S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3:73-76; 1997.
84. Cyranoski, D. Stem cells: 5 things to know before jumping on the iPS bandwagon. Nature 452:406-408; 2008.
85. Czepiel, M.; Balasubramaniyan, V.; Schaafsma, W.; Stancic, M.; Mikkers, H.; Huisman, C.; Boddeke, E.; Copray, S. Differentiation of Induced Pluripotent Stem Cells Into Functional Oligodendrocytes. Glia 59:882-892; 2011.
86. Davies, S. J.; Goucher, D. R.; Doller, C.; Silver, J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J. Neurosci. 19:5810-5822; 1999.
87. Davies, S. J. A.; Fitch, M. T.; Memberg, S. P.; Hall, A. K.; Raisman, G.; Silver, J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390:680-683; 1997.
88. de Castro, R.; Tajrishi, R.; Claros, J.; Stallcup, W.; Castro, D. Differential responses of spinal axons to transection: Influence of the NG2 proteoglycan. Exp. Neurol. 192:299-309; 2005.
89. Deleidi, M.; Hargus, G.; Hallett, P.; Osborn, T.; Isacson, O. Development of histocompatible primate-induced pluri- potent stem cells for neural transplantation. Stem Cells 29:1052-1063; 2011.
90. Deng, J.; Shoemaker, R.; Xie, B.; Gore, A.; LeProust, E. M.; Antosiewicz-Bourget, J.; Egli, D.; Maherali, N.; Park, I.-H.; Yu, J.; Daley, G. Q.; Eggan, K.; Hochedlinger, K.; Thomson, J.; Wang, W.; Gao, Y.; Zhang, K. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat. Biotechnol. 27:353-360; 2009.
91. Devine, M. J.; Ryten, M.; Vodicka, P.; Thomson, A. J.; Burdon, T.; Houlden, H.; Cavaleri, F.; Nagano, M.; Drummond, N. J.; Taanman, J.-W.; Schapira, A. H.; Gwinn, K.; Hardy, J.; Lewis, P. A.; Kunath, T. Parkinson's disease induced pluripotent stem cells with triplication of the a-synuclein locus. Nat. Commun. 2:440; 2011.
92. Dick, E.; Matsa, E.; Young, L. E.; Darling, D.; Denning, C. Faster generation of hiPSCs by coupling high-titer len- tivirus and column-based positive selection. Nat. Protoc. 6:701-714; 2011.
93. Dimos, J.; Rodolfa, K.; Niakan, K.; Weisenthal, L.; Mitsumoto, H.; Chung, W. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321:1218-1221; 2008.
94. Di Stefano, B.; Maffioletti, S. M.; Gentner, B.; Ungaro, F.; Schira, G.; Naldini, L.; Broccoli, V. A microRNA- based system for selecting and maintaining the pluripotent state in human induced pluripotent stem cells. Stem Cells 29:1684-1695; 2011.
95. Doi, A.; Park, I.-H.; Wen, B.; Murakami, P.; Aryee, M. J.; Irizarry, R.; Herb, B.; Ladd-Acosta, C.; Rho, J.; Loewer, S.; Miller, J.; Schlaeger, T.; Daley, G. Q.; Feinberg, A. P. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripo- tent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41:1350-1353; 2009.
96. Donnelly, D. J.; Popovich, P. G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 209:378-388; 2008.
97. Dressel, R.; Nolte, J.; Elsner, L.; Novota, P.; Guan, K.; Streckfuss-Boemeke, K.; Hasenfuss, G.; Jaenisch, R.; Engel, W. Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells. FASEB J. 24:2164-2177; 2010.
98. Drukker, M.; Katchman, H.; Katz, G.; Even-Tov Friedman, S.; Shezen, E.; Hornstein, E.; Mandelboim, O.; Reisner, Y.; Benvenisty, N. Human embryonic stem cells and their differentiated derivates are less susceptible to immune rejection than adult cells. Stem Cells 24:221-229; 2006.
99. Drukker, M.; Katz, G.; Urbach, A.; Schuldiner, M.; Markel, G.; Itskovitz-Eldor, J.; Reubinoff, B.; Mandelboim, O.; Benvenisty, N. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. USA 99:9864-9869; 2002.
100. Ebert, A. D.; Yu, J.; Rose, F. F.; Mattis, V. B.; Lorson, C. L.; Thomson, J. A.; Svendsen, C. N. Induced pluripo- tent stem cells from a spinal muscular atrophy patient. Nature 457:277-280; 2009.
101. Emdad, L.; D'Souza, S.; Kothari, H.; Qadeer, Z.; Germano, I. Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. Stem Cells Dev. 21:404-410; 2012.
102. Emery, E.; Aldana, P.; Bunge, M. B.; Puckett, W.; Srinivasan, A.; Keane, R. W.; Bethea, J.; Levi, A. D. O. Apoptosis after traumatic human spinal cord injury. J. Neurosurg. 89:911-920; 1998.
103. Esteban, M. A.; Wang, T.; Qin, B.; Yang, J.; Qin, D.; Cai, J.; Li, W.; Weng, Z.; Chen, J.; Ni, S.; Chen, K.; Li, Y.; Liu, X.; Xu, J.; Zhang, S.; Li, F.; He, W.; Labuda, K.; Song, Y.; Peterbauer, A.; Wolbank, S.; Redl, H.; Zhong, M.; Cai, D.; Zeng, L.; Pei, D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6:71-79; 2010.
104. Esteban, M. A.; Xu, J.; Yang, J.; Peng, M.; Qin, D.; Li, W.; Jiang, Z.; Chen, J.; Den, K.; Zhong, M.; Cai, J.; Lai, L.; Pei, D. Generation of induced pluripotent stem cell lines from tibetan miniature pig. J. Biol. Chem. 284:17634-17640; 2009.
105. Fairchild, P. J. The challenge of immunogenicity in the quest for induced pluripotency. Nat. Rev. Immunol. 10:868-875; 2010.
106. Faulkner, J.; Keirstead, H. Human embryonic stem cell- derived oligodendrocyte progenitors for the treatment of spinal cord injury. Transpl. Immunol. 15:131-142; 2005.
107. Fawcett, J.; Curt, A.; Steeves, J.; Coleman, W.; Tuszynski, M.; Lammertse, D. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 45:190-205; 2007.
108. Fawcett, J. W.; Asher, R. A. The glial scar and central nervous system repair. Brain Res. Bull. 49:377-391; 1999.
109. Fehlings, M. G.; Tator, C. H. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 132:220-228; 1995.
110. Fitch, M. T.; Silver, J. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp. Neurol. 209:294-301; 2008.
111. Fleming, J. C.; Norenberg, M. D.; Ramsay, D. A.; Dekaban, G. A.; Marcillo, A. E.; Saenz, A. D.; Pasquale- Styles, M.; Dietrich, W. D.; Weaver, L. C. The cellular inflammatory response in human spinal cords after injury. Brain 129:3249-3269; 2006.
112. Frei, E.; Klusman, I.; Schnell, L.; Schwab, M. E. Reactions of olidodendrocytes to spinal cord injury: Cell survival and myelin repair. Exp. Neurol. 163:373-380; 2000.
113. Fu, W.; Wang, S. J.; Zhou, G. D.; Liu, W.; Cao, Y.; Zhang, W. J. Residual undifferentiated cells during differentiation of induced pluripotent stem cells in vitro and in vivo. Stem Cells Dev. 21:521-529; 2012.
114. Fujimoto, Y.; Abematsu, M.; Falk, A.; Tsujimura, K.; Sanosaka, T.; Juliandi, B.; Semi, K.; Namihira, M.; Komiya, S.; Smith, A.; Nakashima, K. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 6:1163-1173; 2012.
115. Fusaki, N.; Ban, H.; Nishiyama, A.; Saeki, K.; Hasegawa, M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci. 85:348-362; 2009.
116. Gan, Q.; Yoshida, T.; McDonald, O. G.; Owens, G. K. Concise review: Epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells 25:2-9; 2007.
117. Ghosh, Z.; Huang, M.; Hu, S.; Wilson, K. D.; Dey, D.; Wu, J. C. Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Cancer Res. 71:5030-5039; 2011.
118. Ghosh, Z.; Wilson, K.; Wu, Y.; Hu, S.; Quertermous, T.; Wu, J. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 5:e8975; 2010.
119. Ghule, P. N.; Medina, R.; Lengner, C. J.; Mandeville, M.; Qiao, M.; Dominski, Z.; Lian, J. B.; Stein, J. L.; Van Wijnen, A. J.; Stein, G. S. Reprogramming the pluripo- tent cell cycle: Restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells. J. Cell. Physiol. 226:1149-1156; 2011.
120. Goh, E. L. K.; Ma, D. K.; Ming, G. L.; Song, H. J. Adult neural stem cells and repair of the adult central nervous system. J. Hematother. Stem Cell Res. 12:671-679; 2003.
121. Gonzalez, F.; Barragan Monasterio, M.; Tiscornia, G.; Montserrat Pulido, N.; Vassena, R.; Batlle Morera, L.; Rodriguez Piza, I.; Belmonte, J. C. I. Generation of mouse- induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc. Natl. Acad. Sci. USA 106:8918-8922; 2009.
122. Gore, A.; Li, Z.; Fung, H.-L.; Young, J. E.; Agarwal, S.; Antosiewicz-Bourget, J.; Canto, I.; Giorgetti, A.; Israel, M. A.; Kiskinis, E.; Lee, J.-H.; Loh, Y.-H.; Manos, P. D.; Montserrat, N.; Panopoulos, A. D.; Ruiz, S.; Wilbert, M. L.; Yu, J.; Kirkness, E. F.; Belmonte, J. C. I.; Rossi, D. J.; Thomson, J. A.; Eggan, K.; Daley, G. Q.; Goldstein, L. S. B.; Zhang, K. Somatic coding mutations in human induced pluripotent stem cells. Nature 471:63-67; 2011.
123. Goritz, C.; Dias, D. O.; Tomilin, N.; Barbacid, M.; Shupliakov, O.; Frisen, J. A pericyte origin of spinal cord scar tissue. Science 333:238-242; 2011.
124. Guenther, M. G.; Frampton, G. M.; Soldner, F.; Hockemeyer, D.; Mitalipova, M.; Jaenisch, R.; Young, R. A. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7:249-257; 2010.
125. Guest, J. D.; Hiester, E. D.; Bunge, R. P. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 192:384-393; 2005.
126. Gutierrez-Aranda, I.; Ramos-Mejia, V.; Bueno, C.; Munoz- Lopez, M.; Real, P. J.; Macia, A.; Sanchez, L.; Ligero, G.; Garcia-Parez, J. L.; Menendez, P. Human induced pluri- potent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells 28:1568-1570; 2010.
127. Han, J.; Yuan, P.; Yang, H.; Zhang, J.; Soh, B. S.; Li, P.; Lim, S. L.; Cao, S.; Tay, J.; Orlov, Y. L.; Lufkin, T.; Ng, H. -H.; Tam, W.-L.; Lim, B. Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 463:1096-1101; 2010.
128. Han, J. W.; Yoon, Y.-S. Induced pluripotent stem cells: Emerging techniques for nuclear reprogramming. Antioxid. Redox Signal. 15:1799-1820; 2011.
129. Han, S. S.; Williams, L. A.; Eggan, K. C. Constructing and deconstructing stem cell models of neurological disease. Neuron 70:626-644; 2011.
130. Hanna, J.; Saha, K.; Pando, B.; van Zon, J.; Lengner, C. J.; Creyghton, M. P.; van Oudenaarden, A.; Jaenisch, R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462:595-603; 2009.
131. Hanna, J.; Wernig, M.; Markoulaki, S.; Sun, C.; Meissner, A.; Cassady, J. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920-1923; 2007.
132. Hargus, G.; Cooper, O.; Deleidi, M.; Levy, A.; Lee, K.; Marlow, E.; Yow, A.; Soldner, F.; Hockemeyer, D.; Hallett, P. J.; Osborn, T.; Jaenisch, R.; Isacson, O. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl. Acad. Sci. USA 107:15921-15926; 2010.
133. Harvey, A. R. Labeling and Identifying Grafted Cells. In: Dunnett, S. B.; Boulton, A. A.; Baker, G. B., eds. Neural Transplantation Methods: Totowa, NJ: Humana Press Inc; 2000:319-361.
134. Harvey, A. R.; Symons, N. A.; Pollett, M. A.; Brooker, G. J.; Bartlett, P. F. Fate of adult neural precursors grafted to adult cortex monitored with a Y-chromosome marker. Neuroreport 8:3939-3943; 1997.
135. Hawkins, R. D.; Hon, G. C.; Lee, L. K.; Ngo, Q.; Lister, R.; Pelizzola, M.; Edsall, L. E.; Kuan, S.; Luu, Y.; Klugman, S.; Antosiewicz-Bourget, J.; Ye, Z.; Espinoza, C.; Agarwahl, S.; Shen, L.; Ruotti, V.; Wang, W.; Stewart, R.; Thomson, J. A.; Ecker, J. R.; Ren, B. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6:479-491; 2010.
136. Hayashi, K.; Hashimoto, M.; Yamazaki, M.; Okawa, A.; Koda, M.; Sakuma, T.; Takahashi, H. Transplantation of astrocytes derived from induced pluripotent stem cells on an experimental spinal cord injury in rats. J. Neurotrauma 26:P83; 2009.
137. Henon, P. R. Human embryonic or adult stem cells: An overview on ethics and perspectives for tissue engineering. Adv. Exp. Med. Biol. 534:2745; 2-3.
138. Hester, M. E.; Murtha, M. J.; Song, S.; Rao, M.; Miranda, C. J.; Meyer, K.; Tian, J.; Boulting, G.; Schaffer, D. V.; Zhu, M. X.; Pfaff, S. L.; Gage, F. H.; Kaspar, B. K. Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes. Mol. Ther. 19:1905-1912; 2011.
139. Hill, C. Contusive spinal cord injury: Endogenous responses of descending systems and effects of acute transplantation of glial restricted precursor cells. Graduate School of the Ohio State University: Ohio State University; 2002:176.
140. Himes, B. T.; Neuhuber, B.; Coleman, C.; Kushner, R.; Swanger, S. A.; Kopen, G. C.; Wagner, J.; Shumsky, J. S.; Fischer, I. Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil. Neural Repair 20:278-296; 2006.
141. Hirami, Y.; Osakada, F.; Takahashi, K.; Okita, K.; Yamanaka, S.; Ikeda, H.; Yoshimura, N.; Takahashi, M. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci. Lett. 458:126-131; 2009.
142. Hiratsuka, M.; Uno, N.; Ueda, K.; Kurosaki, H.; Imaoka, N.; Kazuki, K.; Ueno, E.; Akakura, Y.; Katoh, M.; Osaki, M.; Kazuki, Y.; Nakagawa, M.; Yamanaka, S.; Oshimura, M. Integration-free iPS cells engineered using human artificial chromosome vectors. PLoS One 6:e25961; 2011.
143. Hjelm, B. E.; Rosenberg, J. B.; Szelinger, S.; Sue, L. I.; Beach, T. G.; Huentelman, M. J.; Craig, D. W. Induction of pluripotent stem cells from autopsy donor-derived somatic cells. Neurosci. Lett. 502:219-224; 2011.
144. Hochedlinger, K.; Jaenisch, R. Nuclear reprogramming and pluripotency. Nature 441:1061-1067; 2006.
145. Hochedlinger, K.; Yamada, Y.; Beard, C.; Jaenisch, R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121:465-477; 2005.
146. Hodgetts, S. I.; Simmons, P. J.; Plant, G. W. Human mesenchymal precursor cells (stro-1+) from spinal cord injury patients improve functional recovery and tissue sparing in an acute spinal cord injury rat model. Cell Transplant. In Press; 2012.
147. Hong, H.; Takahashi, K.; Ichisaka, T.; Aoi, T.; Kanagawa, O.; Nakagawa, M.; Okita, K.; Yamanaka, S. Suppression of induced pluripotent stem cell generation by the p53- p21 pathway. Nature 460:1132-1136; 2009.
148. Houle, J.; Tessler, A. Repair of chronic spinal cord injury. Exp. Neurol. 182:247-260; 2003.
149. Hu, B.; Weick, J.; Yu, J.; Ma, L.; Zhang, X.; Thomson, J. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl. Acad. Sci. USA 107:4335-4340; 2010.
150. Huang, J.; Wang, F.; Okuka, M.; Liu, N.; Ji, G.; Ye, X.; Zuo, B.; Li, M.; Liang, P.; Ge, W. W.; Tsibris, J. C. M.; Keefe, D. L.; Liu, L. Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Res. 21:779-792; 2011.
151. Huangfu, D.; Osafune, K.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Chen, S.; Muhlestein, W.; Melton, D. A. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26:1269-1275; 2008.
152. Hussein, S. M.; Batada, N. N.; Vuoristo, S.; Ching, R. W.; Autio, R.; Narva, E.; Ng, S.; Sourour, M.; Hamalainen, R.; Olsson, C.; Lundin, K.; Mikkola, M.; Trokovic, R.; Peitz, M.; Brustle, O.; Bazett-Jones, D. P.; Alitalo, K.; Lahesmaa, R.; Nagy, A.; Otonkoski, T. Copy number variation and selection during reprogramming to pluripotency. Nature 471:58-62; 2011.
153. Ichida, J. K.; Blanchard, J.; Lam, K.; Son, E. Y.; Chung, J. E.; Egli, D.; Loh, K. M.; Carter, A. C.; Di Giorgio, F. P.; Koszka, K.; Huangfu, D.; Akutsu, H.; Liu, D. R.; Rubin, L. L.; Eggan, K. A small-molecule inhibitor of TGF-p signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 5:491-503; 2009.
154. Imaizumi, M.; Nomoto, Y.; Sugino, T.; Miyake, M.; Wada, L.; Nakamura, T.; Omori, K. Potential of induced pluripotent stem cells for the regeneration of the tracheal wall. Ann. Otol. Rhinol. Laryngol. 119:697-703; 2010.
155. Inman, D.; Steward, O. Ascending sensory, but not other long-tract axons, regenerate into the connective tissue matrix that forms at the site of a spinal cord injury in mice. J. Comp. Neurol. 462:431-49; 2003.
156. Ishikawa, K.; Toyama-Sorimachi, N.; Nakada, K.; Morimoto, M.; Imanishi, H.; Yoshizaki, M.; Sasawatari, S.; Niikura, M.; Takenaga, K.; Yonekawa, H.; Hayashi, J. The innate immune system in host mice targets cells with allogenic mitochondrial DNA. J. Exp. Med. 207:2297-2305; 2010.
157. Iwanami, A.; Kaneko, S.; Nakamura, M.; Kanemura, Y.; Mori, H.; Kobayashi, S. Transplantation of human neural stem cells for spinal cord injury in primates. J. Neurosci. Res. 80:182-190; 2005.
158. Jaenisch, R.; Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132:567-582; 2008.
159. Jain, K. K. Ethical and regulatory aspects of embryonic stem cell research. Expert Opin. Biol. Ther. 5:153-162; 2005.
160. James, D.; Noggle, S. A.; Swigut, T.; Brivanlou, A. H. Contribution of human embryonic stem cells to mouse blastocysts. Dev. Biol. 295:90-102; 2006.
161. Jang, J.; Kang, H. C.; Kim, H. S.; Kim, J. Y.; Huh, Y. J.; Kim, D. S.; Yoo, J. E.; Lee, J. A.; Lim, B.; Lee, J.; Yoon, T. M.; Park, I. H.; Hwang, D. Y.; Daley, G. Q.; Kim, D. W. Induced pluripotent stem cell models from X-linked adreno- leukodystrophy patients. Ann. Neurol. 70:402-409; 2011.
162. Jia, F.; Wilson, K.; Sun, N.; Gupta, D.; Huang, M.; Li, Z. A nonviral minicircle vector for deriving human iPS cells. Nat. Methods 7:197-199; 2010.
163. Jiang, J.; Chan, Y.-S.; Loh, Y.-H.; Cai, J.; Tong, G.-Q.; Lim, C.-A.; Robson, P.; Zhong, S.; Ng, H.-H. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell Biol. 10:353-360; 2008.
164. Jiang, M.; Lv, L.; Ji, H.; Yang, X.; Zhu, W.; Cai, L.; Gu, X.; Chai, C.; Huang, S.; Sun, J.; Dong, Q. Induction of pluripotent stem cells transplantation therapy for ischemic stroke. Mol. Cell. Biochem. 354:67-75; 2011.
165. Jones, L.; Sajed, D.; Tuszynski, M. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: A balance of permissiveness and inhibition. J. Neurosci. 23:9276-9288; 2003.
166. Judson, R. L.; Babiarz, J. E.; Venere, M.; Blelloch, R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat. Biotechnol. 27:459-461; 2009.
167. Kaji, K.; Norrby, K.; Paca, A.; Mileikovsky, M.; Mohseni, P.; Woltjen, K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458:771-776; 2009.
168. Kakulas, B. A. Neuropathology: The foundation for new treatments in spinal cord injury. Spinal Cord 42:549-563; 2004.
169. Kang, L.; Wang, J.; Zhang, Y.; Kou, Z.; Gao, S. iPS cells can support full-term development of tetraploid blastocyst- complemented embryos. Cell Stem Cell 5:135-138; 2009.
170. Kapadia, M.; Sakic, B. Autoimmune and inflammatory mechanisms of CNS damage. Prog. Neurobiol. 95:301-333; 2011.
171. Karow, M.; Chavez, C. L.; Farruggio, A. P.; Geisinger, J. M.; Keravala, A.; Jung, W. E.; Lan, F.; Wu, J. C.; Chen-Tsai, Y.; Calos, M. P. Site-specific recombinase strategy to create induced pluripotent stem cells efficiently with plasmid DNA. Stem Cells 29:1696-1704; 2011.
172. Karumbayaram, S.; Novitch, B.; Patterson, M.; Umbach, J.; Richter, L.; Lindgren, A. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 27:806-811; 2009.
173. Kawai, H.; Yamashita, T.; Ohta, Y.; Deguchi, K.; Nagotani, S.; Zhang, X.; Ikeda, Y.; Matsuura, T.; Abe, K. Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J. Cereb. Blood Flow Metab. 30:1487-1493; 2010.
174. Kawamura, T.; Suzuki, J.; Wang, Y. V.; Menendez, S.; Batlle Morera, L.; Raya, A.; Wahl, G. M.; Izpisua Belmonte, J. C. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460:1140-1145; 2009.
175. Keane, R. W.; Davis, A. R.; Dietrich, W. D. Inflammatory and apoptotic signaling after spinal cord injury. J. Neurotrauma 23:335-344; 2006.
176. Keirstead, H. S.; Nistor, G.; Bernal, G.; Totoiu, M.; Cloutier, F.; Sharp, K.; Steward, O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 25:4694-705; 2005.
177. Kigerl, K. A.; McGaughy, V. M.; Popovich, P. G. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J. Comp. Neurol. 494:578-594; 2006.
178. Kim, D.-S.; Lee, J. S.; Leem, J. W.; Huh, Y. J.; Kim, J. Y.; Kim, H.-S.; Park, I.-H.; Daley, G. Q.; Hwang, D.-Y.; Kim, D. -W. Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev. 6:270-281; 2010.
179. Kim, D.; Kim, C.; Moon, J.; Chung, Y.; Chang, M.; Han, B. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:472-476; 2009.
180. Kim, E. Y.; Jeon, K.; Park, H. Y.; Han, Y. J.; Yang, B. C.; Park, S. B.; Chung, H. M.; Park, S. P. Differences between cellular and molecular profiles of induced pluripotent stem cells generated from mouse embryonic fibroblasts. Cell. Reprogram. 12:627-639; 2010.
181. Kim, J.-E.; O'Sullivan, M. L.; Sanchez, C. A.; Hwang, M.; Israel, M. A.; Brennand, K.; Deerinck, T. J.; Goldstein, L. S. B.; Gage, F. H.; Ellisman, M. H.; Ghosh, A. Investigating synapse formation and function using human pluripotent stem cell-derived neurons. Proc. Natl. Acad. Sci. USA 108: 3005-3010;2011.
182. Kim, J.; Chu, J.; Shen, X.; Wang, J.; Orkin, S. H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132:1049-1061; 2008.
183. Kim, J. B.; Sebastiano, V.; Wu, G.; Arauzo-Bravo, M. J.; Sasse, P.; Gentile, L.; Ko, K.; Ruau, D.; Ehrich, M.; van den Boom, D.; Meyer, J.; Huebner, K.; Bernemann, C.; Ortmeier, C.; Zenke, M.; Fleischmann, B. K.; Zaehres, H.; Schoeler, H. R. Oct4-induced pluripotency in adult neural stem cells. Cell 136:411-419; 2009.
184. Kim, K.; Doi, A.; Wen, B.; Ng, K.; Zhao, R.; Cahan, P.; Kim, J.; Aryee, M. J.; Ji, H.; Ehrlich, L. I. R.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; McKinney- Freeman, S.; Naveiras, O.; Yoon, T. J.; Irizarry, R. A. Jung, N.; Seita, J.; Hanna, J.; Murakami, P.; Jaenisch, R. Weissleder, R.; Orkin, S. H.; Weissman, I. L.; Feinberg, A. P. Daley, G. Q. Epigenetic memory in induced pluripotent stem cells. Nature 467:285-290; 2010.
185. Kitazawa, A.; Shimizu, N. Differentiation of mouse induced pluripotent stem cells into neurons using conditioned medium of dorsal root ganglia. Nat. Biotechnol. 28:326-333; 2011.
186. Klapka, N.; Muller, H. Collagen matrix in spinal cord injury. J. Neurotrauma 23:422-435; 2006.
187. Knoepfler, P. S. Deconstructing stem cell tumorigenic- ity: A roadmap to safe regenerative medicine. Stem Cells 27:1050-1056; 2009.
188. Koch, C. A.; Geraldes, P.; Platt, J. L. Immunosuppression by embryonic stem cells. Stem Cells 26:89-98; 2008.
189. Koehler, K. R.; Tropel, P.; Theile, J. W.; Kondo, T.; Cummins, T. R.; Viville, S.; Hashino, E. Extended passaging increases the efficiency of neural differentiation from induced pluripo- tent stem cells. BMC Neurosci. 12:1-14; 2011.
190. Kofidis, T.; deBruin, J. L.; Tanaka, M.; Zwierzchoniewska, M.; Weissman, I.; Fedoseyeva, E.; Haverich, A.; Robbins, R. C. They are not stealthy in the heart: Embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte- based host immune response. Eur. J. Cardiothorac. Surg. 28:461-466; 2005.
191. Kooreman, N. G.; Wu, J. C. Tumorigenicity of pluripotent stem cells: Biological insights from molecular imaging. J. R. Soc. Interface 7:S753-S763; 2010.
192. Krencik, R.; Weick, J. P.; Liu, Y.; Zhang, Z.-J.; Zhang, S.-C. Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nat. Biotech. 29:528-534; 2011.
193. Kwon, B.; Hillyer, J.; Tetzlaff, W. Translational research in spinal cord injury: A survey of opinion from the SCI community. J. Neurotrauma 27:21-33; 2010.
194. Lacroix, S.; Chang, L.; Rose-John, S.; Tuszynski, M. H. Delivery of hyper-interleukin 6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J. Comp. Neurol. 454:213-228; 2002.
195. Lake, B. B.; Fink, J.; Klemetsaune, L.; Fu, X.; Jeffers, J. R.; Zambetti, G. P.; Xu, Y. Context-dependent enhancement of induced pluripotent stem cell reprogramming by silencing puma. Stem Cells 30:888-897; 2012.
196. Lamba, D. A.; Karl, M. O.; Ware, C. B.; Reh, T. A. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 103:12769-12774; 2006.
197. Laurent, L. C.; Ulitsky, I.; Slavin, I.; Tran, H.; Schork, A.; Morey, R.; Lynch, C.; Harness, J. V.; Lee, S.; Barrero, M. J.; Ku, S.; Martynova, M.; Semechkin, R.; Galat, V.; Gottesfeld, J.; Belmonte, J. C. I.; Murry, C.; Keirstead, H. S.; Park, H.-S.; Schmidt, U.; Laslett, A. L.; Muller, F.-J.; Nievergelt, C. M.; Shamir, R.; Loring, J. F. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8:106-118; 2011.
198. Lee, A. S.; Xu, D.; Plews, J. R.; Nguyen, P. K.; Nag, D.; Lyons, J. K.; Han, L.; Hu, S.; Lan, F.; Liu, J.; Huang, M.; Narsinh, K. H.; Long, C. T.; de Almeida, P. E.; Levi, B.; Kooreman, N.; Bangs, C.; Pacharinsak, C.; Ikeno, F.; Yeung, A. C.; Gambhir, S. S.; Robbins, R. C.; Longaker, M. T.; Wu, J. C. Preclinical derivation and imaging of autologously transplanted canine induced pluripotent stem cells. J. Biol. Chem. 286:32697-32704; 2011.
199. Lee, C. H.; Kim, J.-H.; Lee, H. J.; Jeon, K.; Lim, H.; Choi, H. Y.; Lee, E.-R.; Park, S. H.; Park, J.-Y.; Hong, S.; Kim, S.; Cho, S.-G. The generation of iPS cells using nonviral magnetic nanoparticle based transfection. Biomaterials 32:6683-6691; 2011.
200. Lee, E. X.; Lam, D. H.; Wu, C.; Yang, J.; Tham, C. K.; Ng, W. H.; Wang, S. Glioma gene therapy using induced pluri- potent stem cell derived neural stem cells. Mol. Pharm. 8:1515-1524; 2011.
201. Lee, G.; Chambers, S. M.; Tomishima, M. J.; Studer, L. Derivation of neural crest cells from human pluripotent stem cells. Nat. Protoc. 5:688-701; 2010.
202. Lee, G.; Papapetrou, E. P.; Kim, H.; Chambers, S. M.; Tomishima, M. J.; Fasano, C. A.; Ganat, Y. M.; Menon, J.; Shimizu, F.; Viale, A.; Tabar, V.; Sadelain, M.; Studer, L. Modelling pathogenesis and treatment of familial dys- autonomia using patient-specific iPSCs. Nature 461:402-406; 2009.
203. Lee, J. P.; Tsai, D. J.; In Park, K.; Harvey, A. R.; Snyder, E. Y. The dynamics of long-term transgene expression in engrafted neural stem cells. J. Comp. Neurol. 515:83-92; 2009.
204. Lee, S. B.; Seo, D.; Choi, D.; Park, K.-Y.; Holczbauer, A.; Marquardt, J. U.; Conner, E. A.; Factor, V. M.; Thorgeirsson, S. S. Contribution of hepatic lineage stage- specific donor memory to the differential potential of induced mouse pluripotent stem cells. Stem Cells 30:997-1007; 2012.
205. Leskovar, A.; Moriarty, L. J.; Turek, J. J.; Schoenlein, I. A.; Borgens, R. B. The macrophage in acute neural injury: Changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. J. Exp. Biol. 203:1783-1795; 2000.
206. Li, H.; Collado, M.; Villasante, A.; Strati, K.; Ortega, S.; Canamero, M.; Blasco, M. A.; Serrano, M. The Ink4/ Arf locus is a barrier for iPS cell reprogramming. Nature 460:1136-1139; 2009.
207. Li, L.; Baroja, M. L.; Majumdar, A.; Chadwick, K.; Rouleau, A.; Gallacher, L.; Ferber, I.; Lebkowski, J.; Martin, T.; Madrenas, J.; Bhatia, M. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22:448-456; 2004.
208. Li, W.; Wei, W.; Zhu, S.; Zhu, J.; Shi, Y.; Lin, T.; Hao, E.; Hayek, A.; Deng, H.; Ding, S. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4:16-19; 2009.
209. Li, Y.; Yokohama-Tamaki, T.; Tanaka, T. S. Short-term serum-free culture reveals that inhibition of Gsk3p induces the tumor-like growth of mouse embryonic stem cells. PLoS One 6:e21355; 2011.
210. Lian, Q.; Zhang, Y.; Zhang, J.; Zhang, H.; Wu, X. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121:1113-1123; 2010.
211. Liang, G.; Taranova, O.; Xia, K.; Zhang, Y. Butyrate promotes induced pluripotent stem cell generation. J. Biol. Chem. 285:25516-25521; 2010.
212. Liao, B.; Bao, X.; Liu, L.; Feng, S.; Zovoilis, A.; Liu, W.; Xue, Y.; Cai, J.; Guo, X.; Qin, B.; Zhang, R.; Wu, J.; Lai, L.; Teng, M.; Niu, L.; Zhang, B.; Esteban, M. A.; Pei, D. MicroRNA cluster 302-enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition. J. Biol. Chem. 286:17359-17364; 2011.
213. Liao, J.; Cui, C.; Chen, S.; Ren, J.; Chen, J.; Gao, Y. Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell 4:11-15; 2009.
214. Lin, S.-L.; Chang, D. C.; Lin, C.-H.; Ying, S.-Y.; Leu, D.; Wu, D. T. S. Regulation of somatic cell reprogramming through inducible mir-expression. Nucleic Acids Res. 39:105-1065; 2011.
215. Lin, T.; Ambasudhan, R.; Yuan, X.; Li, W.; Hilcove, S.; Abujarour, R.; Lin, X.; Hahm, H. S.; Hao, E.; Hayek, A.; Ding, S. A chemical platform for improved induction of human iPSCs. Nat. Methods 6:805-808; 2009.
216. Lister, R.; Pelizzola, M.; Kida, Y. S.; Hawkins, R. D.; Nery, J. R.; Hon, G.; Antosiewicz-Bourget, J.; O'Malley, R.; Castanon, R.; Klugman, S.; Downes, M.; Yu, R.; Stewart, R.; Ren, B.; Thomson, J. A.; Evans, R. M.; Ecker, J. R. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471:68-73; 2011.
217. Liu, H.; Kim, Y.; Sharkis, S.; Marchionni, L.; Jang, Y.-Y. In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Sci. Transl. Med. 3:82ra39; 2011.
218. Liu, J.; Balehosur, D.; Murray, B.; Kelly, J. M.; Sumer, H.; Verma, P. J. Generation and characterization of reprogrammed sheep induced pluripotent stem cells. Theriogenology 77:338-346; 2012.
219. Liu, X. Z.; Xu, X. M.; Hu, R.; Du, C.; Zhang, S. X.; McDonald, J. W.; Dong, H. X.; Wu, Y. J.; Fan, G. S.; Jacquin, M. F.; Hsu, C. Y.; Choi, D. W. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17:5395-5406; 1997.
220. Liu, Y.; Wang, L.; Kikuiri, T.; Akiyama, K.; Chen, C.; Xu, X.; Yang, R.; Chen, W.; Wang, S.; Shi, S. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-g and TNF-a. Nat. Med. 17:1594-1601; 2011.
221. Loehle, M.; Hermann, A.; Glass, H.; Kempe, A.; Schwarz, S. C.; Kim, J. B.; Poulet, C.; Ravens, U.; Schwarz, J.; Schoeler, H. R.; Storch, A. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells 30:570-579; 2012.
222. Loewer, S.; Cabili, M. N.; Guttman, M.; Loh, Y.-H.; Thomas, K.; Park, I. H.; Garber, M.; Curran, M.; Onder, T.; Agarwal, S.; Manos, P. D.; Datta, S.; Lander, E. S.; Schlaeger, T. M.; Daley, G. Q.; Rinn, J. L. Large inter- genic noncoding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat. Genet. 42:1113-1137; 2010.
223. Loh, Y. H.; Wu, Q.; Chew, J. L.; Vega, V. B.; Zhang, W. W.; Chen, X.; Bourque, G.; George, J.; Leong, B.; Liu, J.; Wong, K. Y.; Sung, K. W.; Lee, C. W. H.; Zhao, X. D.; Chiu, K. P.; Lipovich, L.; Kuznetsov, V. A.; Robson, P.; Stanton, L. W.; Wei, C. L.; Ruan, Y. J.; Lim, B.; Ng, H. H. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38:431-440; 2006.
224. Lopez, M.; Valenzuela, J.; Alvarez, F.; Lopez-Alvarez, M.; Cecilia, G.; Paricio, P. Long-term problems related to immunosuppression. Transpl. Immunol. 17:31-35; 2006.
225. Lowry, W. E.; Richter, L.; Yachechko, R.; Pyle, A. D.; Tchieu, J.; Sridharan, R.; Clark, A. T.; Plath, K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA 105:2883-2888; 2008.
226. Lui, K. O.; Boyd, A. S.; Cobbold, S. P.; Waldmann, H.; Fairchild, P. J. A role for regulatory T cells in acceptance of ESC-derived tissues transplanted across an major histocompatibility complex barrier. Stem Cells 28:1905-1914; 2010.
227. Lyssiotis, C. A.; Foreman, R. K.; Staerk, J.; Garcia, M.; Mathur, D.; Markoulaki, S.; Hanna, J.; Lairson, L. L.; Charette, B. D.; Bouchez, L. C.; Bollong, M.; Kunick, C.; Brinker, A.; Cho, C. Y.; Schultz, P. G.; Jaenisch, R. Reprogramming of murine fibroblasts to induced pluri- potent stem cells with chemical complementation of Klf4. Proc. Natl. Acad. Sci. USA 106:8912-8917; 2009.
228. MacArthur, B. D.; Please, C. P.; Oreffo, R. O. C. Stochasticity and the Molecular Mechanisms of Induced Pluripotency. PLoS One 3:e3086; 2008.
229. Madhavan, L.; Collier, T. A synergistic approach for neural repair: Cell transplantation and induction of endogenous precursor cell activity. Neuropharmacology 58:835-844; 2010.
230. Maekawa, M.; Yamaguchi, K.; Nakamura, T.; Shibukawa, R.; Kodanaka, I.; Ichisaka, T.; Kawamura, Y.; Mochizuki, H.; Goshima, N.; Yamanaka, S. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 474:225-230; 2011.
231. Magill, G.; Neaves, W. B. Ontological and ethical implications of direct nuclear reprogramming. Kennedy Inst. Ethics J. 19:23-32; 2009.
232. Maherali, N.; Sridharan, R.; Xie, W.; Utikal, J.; Eminli, S.; Arnold, K.; Stadtfeld, M.; Yachechko, R.; Tchieu, J.; Jaenisch, R.; Plath, K.; Hochedlinger, K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70; 2007.
233. Maier, L.; Schwab, J. M. Sprouting, regeneration and circuit formation in the injured spinal cord: Factors and activity. Philos. Trans. R. Soc. Lond. Biol. Sci. 381:1611-1684; 2006.
234. Major, T.; Menon, J.; Auyeung, G.; Soldner, F.; Hockemeyer, D.; Jaenisch, R.; Tabar, V. Transgene excision has no impact on in vivo integration of human iPS derived neural precursors. PLoS One 6:e24687; 2011.
235. Mali, P.; Chou, B.-K.; Yen, J.; Ye, Z.; Zou, J.; Dowey, S.; Brodsky, R. A.; Ohm, J. E.; Yu, W.; Baylin, S. B.; Yusa, K.; Bradley, A.; Meyers, D. J.; Mukherjee, C.; Cole, P. A.; Cheng, L. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 28:713-720; 2010.
236. Marchetto, M.; Yeo, G.; Kainohana, O.; Marsala, M.; Gage, F.; Muotri, A. Transcriptional signature and memory retention of human induced pluripotent stem cells. PLoS One 4:e7076; 2009.
237. Marchetto, M. C.; Brennand, K. J.; Boyer, L. F.; Gage, F. H. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: Progress and promises. Hum. Mol. Genet. 20:R109-R115; 2011.
238. Marchetto, M. C. N.; Carromeu, C.; Acab, A.; Yu, D.; Yeo, G. W.; Mu, Y.; Chen, G.; Gage, F. H.; Muotri, A. R. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143:527-539; 2010.
239. Marion, R. M.; Blasco, M. A. Telomere rejuvenation during nuclear reprogramming. Curr. Opin. Biotechnol. 20:190-196; 2010.
240. Marion, R. M.; Strati, K.; Li, H.; Murga, M.; Blanco, R.; Ortega, S.; Fernandez-Capetillo, O.; Serrano, M.; Blasco, M. A. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460:1149-1155; 2009.
241. Markman, J. L.; Silvers, R. M.; Ndoye, A. M. N.; Geary, K. R.; Alvarado, D.; Smith, J. A.; Daniel, R. HIV-1 integration site preferences in pluripotent cells. Front. Biosci. (Elite Ed.) 3:453-462; 2011.
242. Marson, A.; Foreman, R.; Chevalier, B.; Bilodeau, S.; Kahn, M.; Young, R. A.; Jaenisch, R. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3:132-135; 2008.
243. Martins-Taylor, K.; Nisler, B. S.; Taapken, S. M.; Compton, T.; Crandall, L.; Montgomery, K. D.; Lalande, M.; Xu, R.-H. Recurrent copy number variations in human induced pluripotent stem cells. Nat. Biotechnol. 29:488-491; 2011.
244. Martins-Taylor, K.; Xu, R.-H. Concise review: Genomic stability of human induced pluripotent stem cells. Stem Cells 30:22-27; 2012.
245. Mathew, R.; Jia, W.; Sharma, A.; Zhao, Y.; Clarke, L. E.; Cheng, X.; Wang, H.; Salli, U.; Vrana, K. E.; Robertson, G. P.; Zhu, J.; Wang, S. Robust activation of the human but not mouse telomerase gene during the induction of pluri- potency. FASEB J. 24:2702-2715; 2010.
246. Mayshar, Y.; Ben-David, U.; Lavon, N.; Biancotti, J.-C.; Yakir, B.; Clark, A. T.; Plath, K.; Lowry, W. E.; Benvenisty, N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7:521-531; 2010.
247. McDonald, J. W.; Althomsons, S. P.; Hyrc, K. L.; Choi, D. W.; Goldberg, M. P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 4:291-297; 1998.
248. McDonald, J. W.; Belegu, V. Demyelination and remyeli- nation after spinal cord injury. J. Neurotrauma 23:345-359; 2006.
249. McDonald, J. W.; Howard, M. J. Repairing the damaged spinal cord: A summary of our early success with embryonic stem cell transplantation and remyelination. Prog. Brain Res. 137:299-309; 2002.
250. McKeon, R. J.; Höke, A.; Silver, J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp. Neurol. 136:32-43; 1995.
251. Meissner, A.; Jaenisch, R. Mammalian nuclear transfer. Dev. Dyn. 235:2460-2469; 2006.
252. Meissner, A.; Wernig, M.; Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripo- tent stem cells. Nat. Biotechnol. 25:1177-1181; 2007.
253. Melton, C.; Blelloch, R. MicroRNA regulation of embryonic stem cell self-renewal and differentiation. Adv. Exp. Med. Biol. 695:105-117; 2010.
254. Mitsui, T.; Shumsky, J.; Lepore, A.; Murray, M.; Fischer, I. Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry. J. Neurosci. 25:9624-9636; 2005.
255. Miura, K.; Okada, Y.; Aoi, T.; Okada, A.; Takahashi, K.; Okita, K.; Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Ohnuki, M.; Ogawa, D.; Ikeda, E.; Okano, H.; Yamanaka, S. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 27:743-745; 2009.
256. Moloney, T. C.; Dockery, P.; Windebank, A. J.; Barry, F. P.; Howard, L.; Dowd, E. Survival and immunogenicity of mesenchymal stem cells from the green fluorescent protein transgenic rat in the adult rat brain. Neurorehabil. Neural Repair 24:645-656; 2010.
257. Moon, J.-H.; Heo, J. S.; Kim, J. S.; Jun, E. K.; Lee, J. H.; Kim, A.; Kim, J.; Whang, K. Y.; Kang, Y.-K.; Yeo, S.; Lim, H.-J.; Han, D. W.; Kim, D.-W.; Oh, S.; Yoon, B. S.; Schoeler, H. R.; You, S. Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1. Cell Res. 21:1305-1315; 2011.
258. Moriguchi, H.; Chung, R. T.; Sato, C. Tumorigenicity of human induced pluripotent stem cells depends on the balance of gene expression between p21 and p53. Hepatology 51:1088-1089; 2010.
259. Nagy, K.; Sung, H.-K.; Zhang, P.; Laflamme, S.; Vincent, P.; Agha-Mohammadi, S.; Woltjen, K.; Monetti, C.; Michael, I. P.; Smith, L. C.; Nagy, A. Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev. 7:693-702; 2011.
260. Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Takahashi, K.; Ichisaka, T.; Aoi, T. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26:101-106; 2008.
261. Nakagawa, M.; Takizawa, N.; Narita, M.; Ichisaka, T.; Yamanaka, S. Promotion of direct reprogramming by transformation-deficient Myc. Proc. Natl. Acad. Sci. USA 107:14152-14157; 2010.
262. Nakayama, T.; Momoki-Soga, T.; Inoue, N. Astrocyte- derived factors instruct differentiation of embryonic stem cells into neurons. Neurosci. Res. 46:241-249; 2003.
263. Narsinh, K. H.; Plews, J.; Wu, J. C. Comparison of human induced pluripotent and embryonic stem cells: Fraternal or identical twins? Mol. Ther. 19:635-638; 2011.
264. Nashmi, R.; Fehlings, M. G. Mechanisms of axonal dysfunction after spinal cord injury: With an emphasis on the role of voltage-gated potassium channels. Brain Res. Rev. 38:165-191; 2001.
265. Nelson, T. J.; Martinez-Fernandez, A.; Yamada, S.; Perez- Terzic, C.; Ikeda, Y.; Terzic, A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120:408-16; 2009.
266. Neveu, P.; Kye, M. J.; Qi, S.; Buchholz, D. E.; Clegg, D. O.; Sahin, M.; Park, I.-H.; Kim, K.-S.; Daley, G. Q.; Kornblum, H. I.; Shraiman, B. I.; Kosik, K. S. MicroRNA profiling reveals two distinct p53-related human pluripo- tent stem cell states. Cell Stem Cell 7:671-681; 2010.
267. Newman, A. M.; Cooper, J. B. Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7:258-262; 2010.
268. Nguyen, H. N.; Byers, B.; Cord, B.; Shcheglovitov, A.; Byrne, J.; Gujar, P.; Kee, K.; Schule, B.; Dolmetsch, R. E.; Langston, W.; Palmer, T. D.; Pera, R. R. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8:267-280; 2011.
269. Nishimura, K.; Sano, M.; Ohtaka, M.; Furuta, B.; Umemura, Y.; Nakajima, Y.; Ikehara, Y.; Kobayashi, T.; Segawa, H.; Takayasu, S.; Sato, H.; Motomura, K.; Uchida, E.; Kanayasu-Toyoda, T.; Asashima, M.; Nakauchi, H.; Yamaguchi, T.; Nakanishia, M. Development of defective and persistent sendai virus vector: A unique gene delivery/ expression system ideal for cell reprogramming. J. Biol. Chem. 286:4760-771; 2011.
270. Norenberg, M. D.; Smith, J.; Marcillo, A. The pathology of human spinal cord injury: Defining the problems. J. Neurotrauma 21:429-440; 2004.
271. Nori, S.; Okada, Y.; Yasuda, A.; Tsuji, O.; Takahashi, Y. Kobayashi, Y.; Fujiyoshi, K.; Koike, M.; Uchiyama, Y. Ikeda, E.; Toyama, Y.; Yamanaka, S.; Nakamura, M. Okano, H. Grafted human-induced pluripotent stem-cell- derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc. Natl. Acad. Sci. USA 108:16825-16830; 2011.
272. Nussbaum, J.; Minami, E.; Laflamme, M. A.; Virag, J. A. I.; Ware, C. B.; Masino, A.; Muskheli, V.; Pabon, L.; Reinecke, H.; Murry, C. E. Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J. 21:1345-1357; 2007.
273. Oda, Y.; Yoshimura, Y.; Ohnishi, H.; Tadokoro, M.; Katsube, Y.; Sasao, M.; Kubo, Y.; Hattori, K.; Saito, S.; Horimoto, K.; Yuba, S.; Ohgushi, H. Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J. Biol. Chem. 285:29270-29278; 2010.
274. Ogawa, S.-I.; Tokumoto, Y.; Miyake, J.; Nagamune, T. Immunopanning selection of A2B5-positive cells increased the differentiation efficiency of induced pluri- potent stem cells into oligodendrocytes. Neurosci. Lett. 489:79-83; 2011.
275. Ogawa, S.-I.; Tokumoto, Y.; Miyake, J.; Nagamune, T. Induction of oligodendrocyte differentiation from adult human fibroblast-derived induced pluripotent stem cells. In Vitro Cell. Dev. Biol. Anim. 47:464-469; 2011.
276. Ohm, J. E.; Mali, P.; Van Neste, L.; Berman, D. M.; Liang, L.; Pandiyan, K.; Briggs, K. J.; Zhang, W.; Argani, P.; Simons, B.; Yu, W.; Matsui, W.; Van Criekinge, W.; Rassool, F. V.; Zambidis, E.; Schuebel, K. E.; Cope, L.; Yen, J.; Mohammad, H. P.; Cheng, L.; Baylin, S. B. Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. Cancer Res. 70:7662-7673; 2010.
277. Oki, K.; Tatarishvili, J.; Woods, J.; Koch, P.; Wattananit, S.; Mine, Y.; Monni, E.; Prietro, D. T.; Ahlenius, H.; Ladewig, J.; Brustle, O.; Lindvall, O.; Kokaia, Z. Human induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells 30:1120-1133; 2012.
278. Okita, K.; Hong, H.; Takahashi, K.; Yamanaka, S. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat. Protoc. 5:418-428; 2010.
279. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317; 2007.
280. Okita, K.; Matsumura, Y.; Sato, Y.; Okada, A.; Morizane, A.; Okamoto, S.; Hong, H.; Nakagawa, M.; Tanabe, K.; Tezuka, K.; Shibata, T.; Kunisada, T.; Takahashi, M.; Takahashi, J.; Saji, H.; Yamanaka, S. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8:409H2; 2011.
281. Okita, K.; Nakagawa, M.; Hong, H. J.; Ichisaka, T.; Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953; 2008.
282. Onorati, M.; Camnasio, S.; Binetti, M.; Jung, C. B.; Moretti, A.; Cattaneo, E. Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells. Mol. Cell. Neurosci. 43:287-295; 2010.
283. Osafune, K.; Caron, L.; Borowiak, M.; Martinez, R. J.; Fitz-Gerald, C. S.; Sato, Y.; Cowan, C. A.; Chien, K. R.; Melton, D. A. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 26:313-315; 2008.
284. Panopoulos, A. D.; Yanes, O.; Ruiz, S.; Kida, Y. S.; Diep, D.; Tautenhahn, R.; Herrerias, A.; Batchelder, E. M.; Plongthongkum, N.; Lutz, M.; Berggren, W. T.; Zhang, K.; Evans, R. M.; Siuzdak, G.; Izpisua Belmonte, J. C. The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Res. 22:168-177; 2012.
285. Papapetrou, E. P.; Sadelain, M. Generation of transgene- free human induced pluripotent stem cells with an excisable single polycistronic vector. Nat. Protocols 6:1251-1273; 2011.
286. Papapetrou, E. P.; Tomishima, M. J.; Chambers, S. M.; Mica, Y.; Reed, E.; Menon, J.; Tabar, V.; Mo, Q.; Studer, L.; Sadelain, M. Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc. Natl. Acad. Sci. USA 106:12759-12764; 2009.
287. Parameswaran, S.; Balasubramanian, S.; Babai, N.; Qiu, F.; Eudy, J. D.; Thoreson, W. B.; Ahmad, I. Induced pluri- potent stem cells generate both retinal ganglion cells and photoreceptors: Therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration. Stem Cells 28:695-703; 2010.
288. Park, E.; Velumian, A. A.; Fehlings, M. G. The role of excitotoxicity in secondary mechanisms of spinal cord injury: A review with an emphasis on the implications for white matter degeneration. J. Neurotrauma 21:754-774; 2004.
289. Park, I.-H.; Lerou, P. H.; Zhao, R.; Huo, H.; Daley, G. Q. Generation of human-induced pluripotent stem cells. Nat. Protoc. 3:1180-1186; 2008.
290. Pasterkamp, R. J.; Anderson, P. N.; Verhaagen, J. Peripheral nerve injury fails to induce growth of lesioned ascending dorsal column axons into spinal cord scar tissue expressing the axon repellent Semaphorin3A. Eur. J. Neurosci. 13:457-471; 2001.
291. Pearl, J. I.; Lee, A. S.; Leveson-Gower, D. B.; Sun, N.; Ghosh, Z.; Lan, F.; Ransohoff, J.; Negrin, R. S.; Davis, M. M.; Wu, J. C. Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stem Cell 8:309-317; 2011.
292. Pedrosa, E.; Sandler, V.; Shah, A.; Carroll, R.; Chang, C.; Rockowitz, S.; Guo, X.; Zheng, D.; Lachman, H. M. Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells. J. Neurogenet. 25: 88-103; 2011.
293. Pfaff, N.; Fiedler, J.; Holzmann, A.; Schambach, A.; Moritz, T.; Cantz, T.; Thum, T. miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2. EMBO Rep. 12:1153-1159; 2011.
294. Pick, M.; Stelzer, Y.; Bar-Nur, O.; Mayshar, Y.; Eden, A.; Benvenisty, N. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 27:2686-2690; 2009.
295. Plath, K.; Lowry, W. E. Progress in understanding reprogramming to the induced pluripotent state. Nat. Rev. Gen. 12:253-265; 2011.
296. Polo, J. M.; Liu, S.; Figueroa, M. E.; Kulalert, W.; Eminli, S.; Tan, K. Y.; Apostolou, E.; Stadtfeld, M.; Li, Y.; Shioda, T.; Natesan, S.; Wagers, A. J.; Melnick, A.; Evans, T.; Hochedlinger, K. Cell type of origin influences the molecular and functional properties of mouse induced pluripo- tent stem cells. Nat. Biotechnol. 28:848-855; 2010.
297. Popovich, P. G.; Jones, T. B. Manipulating neuroinflam- matory reactions in the injured spinal cord: Back to basics. Trends Pharmacol. Sci. 24:13-17; 2003.
298. Popovich, P. G.; Wei, P.; Stokes, B. T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377:443-64; 1997.
299. Pouya, A.; Satarian, L.; Kiani, S.; Javan, M.; Baharvand, H. Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination. PLoS One 6:e27925; 2011.
300. Pralong, D.; Trounson, A. O.; Verma, P. J. Cell fusion for reprogramming pluripotency-Toward elimination of the pluripotent genome. Stem Cell Rev. 2:331-340; 2006.
301. Prigione, A.; Adjaye, J. Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells. Int. J. Dev. Biol. 54:1729-1741; 2010.
302. Prigione, A.; Lichtner, B.; Kuhl, H.; Struys, E. A.; Wamelink, M.; Lehrach, H.; Ralser, M.; Timmermann, B.; Adjaye, J. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming. Stem Cells 29:1338-1348; 2011.
303. Profyris, C.; Cheema, S. S.; Zang, D.; Azari, M. F.; Boyle, K.; Petratos, S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol. Dis. 15:415-436; 2004.
304. Puckett, W. R.; Hiester, E. D.; Norenberg, M. D.; Marcillo, A. E.; Bunge, R. P. The astroglial response to Wallerian degeneration after spinal cord injury in humans. Exp. Neurol. 148:424-432; 1997.
305. Ramos-Mejia, V.; Munoz-Lopez, M.; Garcia-Perez, J. L.; Menendez, P. iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability. Cell Res. 20:1092-1095; 2010.
306. Reier, P. J.; Houle, J. D. The Glial Scar: It's bearing on axonal elongation and transplantion approaches to CNS repair. Adv. Neurol. 47:87-138; 1988.
307. Rhee, Y.-H.; Ko, J.-Y.; Chang, M.-Y.; Yi, S.-H.; Kim, D.; Kim, C.-H.; Shim, J.-W.; Jo, A. Y.; Kim, B.-W.; Lee, H.; Lee, S.-H.; Suh, W.; Park, C.-H.; Koh, H.-C.; Lee, Y.-S.; Lanza, R.; Kim, K.-S.; Lee, S.-H. Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J. Clin. Invest. 121:2326-2335; 2011.
308. Rideout, W. M.; Eggan, K.; Jaenisch, R. Nuclear cloning and epigenetic reprogramming of the genome. Science 293:1093-1098; 2001.
309. Risling, M.; Fried, K.; Linda, H.; Carlstedt, T.; Cullheim, S. Regrowth of motor axons following spinal-cord lesions. Distribution of laminin and collagen in the CNS scar tissue. Brain Res. Bull. 30:405-14; 1993.
310. Robertson, J. A. Ethics and policy in embryonic stem cell research. Kennedy Inst. Ethics J. 9:109-136; 1999.
311. Robertson, N. J.; Brook, F. A.; Gardner, R. L.; Cobbold, S. P.; Waldmann, H.; Fairchild, P. J. Embryonic stem cell- derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc. Natl. Acad. Sci. USA 104:20920-20925; 2007.
312. Rodriguez-Piza, I.; Richaud-Patin, Y.; Vassena, R.; Gonzalez, F.; Jose Barrero, M.; Veiga, A.; Raya, A.; Izpisua Belmonte, J. C. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions. Stem Cells 28:36-44; 2010.
313. Romano, G. Stem cell transplantation therapy: Controversy over ethical issues and clinical relevance. Drug News Perspect. 17:637-645; 2004.
314. Ronaghi, M.; Erceg, S.; Moreno-Manzano, V.; Stojkovic, M. Challenges of stem cell therapy for spinal cord injury: Human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells 28:93-99; 2010.
315. Ron-Bigger, S.; Bar-Nur, O.; Isaac, S.; Bocker, M.; Lyko, F.; Eden, A. Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming. Stem Cells 28:1349-1354; 2010.
316. Ross, P. J.; Suhr, S. T.; Maria Rodriguez, R.; Chang, E.-A.; Wang, K.; Siripattarapravat, K.; Ko, T.; Bernardo Cibelli, J. Human-induced pluripotent stem cells produced under xeno-free conditions. Stem Cells Dev. 19:1221-1229; 2010.
317. Rossi, S. L.; Keirstead, H. S. Stem cells and spinal cord regeneration. Curr. Opin. Biotechnol. 20:552-562; 2009.
318. Rowland, J. W.; Hawryluk, G. W. J.; Kwon, B.; Fehlings, M. G. Current status of acute spinal cord injury pathophysiology and emerging therapies: Promise on the horizon. Neurosurg. Focus 25:E2; 2008.
319. Roy, N. S.; Cleren, C.; Singh, S. K.; Yang, L.; Beal, M. F.; Goldman, S. A. Functional engraftment of human ES cell- derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 13:385-385; 2007.
320. Rudge, J. S.; Silver, J. Inhibition of neurite outgrowth on astroglial scars in vitro. J. Neurosci. 10:3594-3603; 1990.
321. Sanchez-Danes, A.; Consiglio, A.; Richaud, Y.; Rodriguez- Piza, I.; Dehay, B.; Edel, M.; Bove, J.; Memo, M.; Vila, M.; Raya, A.; Izpisua Belmonte, J. C. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of Lmx1A in human embryonic stem cells and iPS cells. Hum. Gene Ther. 23:56-69; 2012.
322. Sartore, R. C.; Campos, P. B.; Trujillo, C. A.; Ramalho, B. L.; Negraes, P. D.; Paulsen, B. S.; Meletti, T.; Costa, E. S.; Chicaybam, L.; Bonamino, M. H.; Ulrich, H.; Rehen, S. K. Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation. PLoS One 6:e20667; 2011.
323. Sasaki, N.; Hirano, T.; Kobayashi, K.; Toyoda, M.; Miyakawa, Y.; Okita, H.; Kiyokawa, N.; Akutsu, H.; Umezawa, A.; Nishihara, S. Chemical inhibition of sulfation accelerates neural differentiation of mouse embryonic stem cells and human induced pluripotent stem cells. Biochem. Biophys. Res. Commun. 401:480-86; 2010.
324. Schwab, M. E.; Bartholdi, D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 76:319-370; 1996.
325. Seibler, P.; Graziotto, J.; Jeong, H.; Simunovic, F.; Klein, C.; Krainc, D. Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J. Neurosci. 31:5970-5976; 2011.
326. Sekhon, L. H. S.; Fehlings, M. G. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26:S2-S12; 2001.
327. Seki, T.; Yuasa, S.; Oda, M.; Egashira, T.; Yae, K.; Kusumoto, D.; Nakata, H.; Tohyama, S.; Hashimoto, H.; Kodaira, M.; Okada, Y.; Seimiya, H.; Fusaki, N.; Hasegawa, M.; Fukuda, K. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7:11-14; 2010.
328. Sharp, J.; Frame, J.; Siegenthaler, M.; Nistor, G.; Keirstead, H. S. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 28:152-163; 2010.
329. Shi, Y.; Desponts, C.; Do, J. T.; Hahm, H. S.; Schoeler, H. R.; Ding, S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3:568-574; 2008.
330. Shi, Y.; Do, J. T.; Desponts, C.; Hahm, H. S.; Schoeler, H. R.; Ding, S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2:525-528; 2008.
331. Shields, C. B.; Zhang, Y. P.; Shields, L. B. E.; Han, Y.; Burke, D. A.; Mayer, N. W. The therapeutic window for spinal cord decompression in a rat spinal cord injury model. J. Neurosurg. Spine 3:302-307; 2005.
332. Shimada, H.; Hashimoto, Y.; Nakada, A.; Shigeno, K.; Nakamura, T. Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia. Biochem. Biophys. Res. Commun. 417:659-664; 2012.
333. Silver, J.; Miller, J. H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5:146-156; 2004.
334. Singh, A. M.; Dalton, S. The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 5:141-149; 2009.
335. Singla, D. K.; Long, X.; Glass, C.; Singla, R. D.; Yan, B. Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium. Mol. Pharm. 8:1573-1581; 2011.
336. Skene, L. Recent developments in stem cell research: Social, ethical, and legal issues for the future. Ind. J. Global Legal Stud. 17:211-244; 2010.
337. Smith, K. P.; Luong, M. X.; Stein, G. S. Pluripotency: Toward a gold standard for human ES and iPS cells. J. Cell. Physiol. 220:21-29; 2009.
338. Soldner, F.; Hockemeyer, D.; Beard, C.; Gao, Q.; Bell, G. W.; Cook, E. G.; Hargus, G.; Blak, A.; Cooper, O.; Mitalipova, M.; Isacson, O.; Jaenisch, R. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136:964-977; 2009.
339. Sommer, C. A.; Sommer, A. G.; Longmire, T. A.; Christo- doulou, C.; Thomas, D. D.; Gostissa, M.; Alt, F. W.; Murphy, G. J.; Kotton, D. N.; Mostoslavsky, G. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 28:64-74; 2010.
340. Sommer, C. A.; Stadtfeld, M.; Murphy, G. J.; Hochedlinger, K.; Kotton, D. N.; Mostoslavsky, G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27:543-549; 2009.
341. Sperger, J. M.; Chen, X.; Draper, J. S.; Antosiewicz, J. E.; Chon, C. H.; Jones, S. B.; Brooks, J. D.; Andrews, P. W.; Brown, P. O.; Thomson, J. A. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. USA 100:13350-13355; 2003.
342. Sroga, J. M.; Jones, T. B.; Kigerl, K. A.; McGaughy, V. M.; Popovich, P. G. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J. Comp. Neurol. 462:223-240; 2003.
343. Stadtfeld, M.; Apostolou, E.; Akutsu, H.; Fukuda, A.; Follett, P.; Natesan, S.; Kono, T.; Shioda, T.; Hochedlinger, K. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465:175-181; 2010.
344. Stadtfeld, M.; Maherali, N.; Breault, D. T.; Hochedlinger, K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2:230-240; 2008.
345. Stadtfeld, M.; Nagaya, M.; Utikal, J.; Weir, G.; Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322:945-949; 2008.
346. Stelzer, Y.; Yanuka, O.; Benvenisty, N. Global analysis of parental imprinting in human parthenogenetic induced pluri- potent stem cells. Nat. Struct. Mol. Biol. 18:735-741; 2011.
347. Stripecke, R.; Carmen Villacres, M.; Skelton, D.; Satake, N.; Halene, S.; Kohn, D. Immune response to green fluorescent protein: Implications for gene therapy. Gene Ther. 6:1305-1312; 1999.
348. Studer, L. The Nervous System. In: Lanza, R., ed. Essentials of stem cell biology. San Diego, CA: Elsevier; 2009:169-178.
349. Subramanyam, D.; Lamouille, S.; Judson, R. L.; Liu, J. Y.; Bucay, N.; Derynck, R.; Blelloch, R. Multiple targets of miR-and miR-promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat. Biotechnol. 29:443-448; 2011.
350. Sugii, S.; Kida, Y.; Kawamura, T.; Suzuki, J.; Vassena, R.; Yin, Y.-Q.; Lutz, M. K.; Berggren, T.; Izpisua Belmonte, J. C.; Evans, R. M. Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells. Proc. Natl. Acad. Sci. USA 107:3558-3563; 2010.
351. Suhr, S. T.; Chang, E. A.; Rodriguez, R. M.; Wang, K.; Ross, P. J.; Beyhan, Z.; Murthy, S.; Cibelli, J. B. Telomere dynamics in human cells reprogrammed to pluripotency. PLoS One 4:e8124; 2009.
352. Sullivan, G. J.; Bai, Y.; Fletcher, J.; Wilmut, I. Induced pluripotent stem cells: Epigenetic memories and practical implications. Mol. Hum. Reprod. 16:880-885; 2010.
353. Sun, Y.; Kong, W.; Falk, A.; Hu, J.; Zhou, L.; Pollard, S.; Smith, A. CD(prominin) negative human neural stem cells are clonogenic and tripotent. PLoS One 4:e5498; 2009.
354. Suzuki, H.; Shibata, R.; Kito, T.; Ishii, M.; Li, P.; Yoshikai, T.; Nishio, N.; Ito, S.; Numaguchi, Y.; Yamashita, J. K.; Murohara, T.; Isobe, K. Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells. BMC Cell Biol. 11:72; 2010.
355. Svendsen, C. N.; ter Borg, M. G.; Armstrong, R. J. E.; Rosser, A. E.; Chandran, S.; Ostenfeld, T.; Caldwell, M. A. A new method for the rapid and long term growth of human neural precursor cells. J. Neurosci. Methods 85:141-152; 1998.
356. Swijnenburg, R.-J.; Schrepfer, S.; Govaert, J. A.; Cao, F.; Ransohoff, K.; Sheikh, A. Y.; Haddad, M.; Connolly, A. J.; Davis, M. M.; Robbins, R. C.; Wu, J. C. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl. Acad. Sci. USA 105:12991-12996; 2008.
357. Swijnenburg, R.-J.; Tanaka, M.; Vogel, H.; Baker, J.; Kofidis, T.; Gunawan, F.; Lebl, D. R.; Caffarelli, A. D.; de Bruin, J. L.; Fedoseyeva, E. V.; Robbins, R. C. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112:I166-I172; 2005.
358. Swistowski, A.; Peng, J.; Liu, Q.; Mali, P.; Rao, M. S.; Cheng, L.; Zeng, X. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 28:1893-1904; 2010.
359. Taapken, S. M.; Nisler, B. S.; Newton, M. A.; Sampsell- Barron, T. L.; Leonhard, K. A.; McIntire, E. M.; Montgomery, K. D. Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat. Biotechnol. 29:313-314; 2011.
360. Takahashi, K. Direct reprogramming 101. Dev. Growth Differ. 52:319-333; 2010.
361. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluri- potent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872; 2007.
362. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676; 2006.
363. Tang, C.; Lee, A. S.; Volkmer, J. P.; Sahoo, D.; Nag, D.; Mosley, A. R.; Inlay, M. A.; Ardehali, R.; Chavez, S. L.; Pera, R. R.; Behr, B.; Wu, J. C.; Weissman, I. L.; Drukker, M. An antibody against SSEA-5 glycan on human pluri- potent stem cells enables removal of teratoma-forming cells. Nat. Biotechnol. 29:829-834; 2011.
364. Tang, X. F.; Davies, J. E.; Davies, S. J. A. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 71:427-444; 2003.
365. Taoka, Y.; Okajima, K.; Uchiba, M.; Murakami, K.; Kushi- moto, S.; Johno, M.; Naruo, M.; Okabe, H.; Takatsuki, K. Role of neutrophils in spinal cord injury in the rat. Neuroscience 79:1177-1182; 1997.
366. Teichroeb, J. H.; Betts, D. H.; Vaziri, H. Suppression of the imprinted gene NNAT and X-chromosome gene activation in isogenic human iPS cells. PLoS One 6:e23436; 2011.
367. Tetzlaff, W.; Okon, E. B.; Karimi-Abdolrezaee, S.; Hill, C. E.; Sparling, J. S.; Plemel, J. R.; Plunet, W. T.; Tsai, E. C.; Baptiste, D.; Smithson, L. J.; Kawaja, M. D.; Fehlings, M. G.; Kwon, B. K. A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 28:1611-1682; 2011.
368. Tokumoto, Y.; Ogawa, S.; Nagamune, T.; Miyake, J. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro. J. Biosci. Bioeng. 109:622-628; 2010.
369. Totoiu, M. O.; Keirstead, H. S. Spinal cord injury is accompanied by chronic progressive demyelination. J. Comp. Neurol. 486:373-383; 2005.
370. Touraine, J. L.; Sanhadji, K. Transplantation tolerance induced in humans at the fetal or the neonatal stage. J. Transplant. 2011:760319; 2011.
371. Tsuji, O.; Miura, K.; Okada, Y.; Fujiyoshi, K.; Mukaino, M.; Nagoshi, N.; Kitamura, K.; Kumagai, G.; Nishino, M.; Tomisato, S.; Higashi, H.; Nagai, T.; Katoh, H.; Kohda, K.; Matsuzaki, Y.; Yuzaki, M.; Ikeda, E.; Toyama, Y.; Nakamura, M.; Yamanaka, S.; Okano, H. Therapeutic potential of appropriately evaluated safe-induced pluripo- tent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. USA 107:12704-12709; 2010.
372. Tucker, B. A.; Park, I. H.; Qi, S. D.; Klassen, H. J.; Jiang, C. H.; Yao, J.; Redenti, S.; Daley, G. Q.; Young, M. J. Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS One 6:e18992; 2011.
373. Uemura, T.; Takamatsu, K.; Ikeda, M.; Okada, M.; Kazuki, K.; Ikada, Y.; Nakamura, H. Transplantation of induced pluripotent stem cell-derived neurospheres for peripheral nerve repair. Biochem. Biophys. Res. Commun. 419:130-135; 2012.
374. Utikal, J.; Polo, J. M.; Stadtfeld, M.; Maherali, N.; Kulalert, W.; Walsh, R. M.; Khalil, A.; Rheinwald, J. G.; Hochedlinger, K. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460:1145-1148; 2009.
375. Vaziri, H.; Chapman, K. B.; Guigova, A.; Teichroeb, J.; Lacher, M. D.; Sternberg, H.; Singec, I.; Briggs, L.; Wheeler, J.; Sampathkumar, J.; Gonzalez, R.; Larocca, D.; Murai, J.; Snyder, E.; Andrews, W. H.; Funk, W. D.; West, M. D. Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming. Regen. Med. 5:345-363; 2010.
376. Wang, A.; Tang, Z.; Park, I.-H.; Zhu, Y.; Patel, S.; Daley, G. Q.; Li, S. Induced pluripotent stem cells for neural tissue engineering. Biomaterials 32:5023-5032; 2011.
377. Wang, J. T.; Medress, Z. A.; Barres, B. A. Axon degeneration: Molecular mechanisms of a self-destruction pathway. J. Cell Biol. 196:7-18; 2012.
378. Wang, Q.; Xu, X.; Li, J.; Liu, J.; Gu, H.; Zhang, R.; Chen, J.; Kuang, Y.; Fei, J.; Jiang, C.; Wang, P.; Pei, D.; Ding, S.; Xie, X. Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells. Cell Res. 21:1424-1435; 2011.
379. Wang, W.; Lin, C.; Lu, D.; Ning, Z.; Cox, T.; Melvin, D.; Wang, X.; Bradley, A.; Liu, P. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 105:9290-9295; 2008.
380. Wang, Y.; Baskerville, S.; Shenoy, A.; Babiarz, J. E.; Baehner, L.; Blelloch, R. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat. Genet. 40:1478-1483; 2008.
381. Warren, L.; Manos, P. D.; Ahfeldt, T.; Loh, Y.-H.; Li, H.; Lau, F.; Ebina, W.; Mandal, P. K.; Smith, Z. D.; Meissner, A.; Daley, G. Q.; Brack, A. S.; Collins, J. J.; Cowan, C.; Schlaeger, T. M.; Rossi, D. J. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7:618-630; 2010.
382. Waxman, S. Demyelination in spinal cord injury. J. Neurol. Sci. 91:1-14; 1989.
383. Wernig, M.; Benninger, F.; Schmandt, T.; Rade, M.; Tucker, K. L.; Bussow, H.; Beck, H.; Brustle, O. Functional integration of embryonic stem cell-derived neurons in vivo. J. Neurosci. 24:5258-5268; 2004.
384. Wernig, M.; Lengner, C. J.; Hanna, J.; Lodato, M. A.; Steine, E.; Foreman, R.; Staerk, J.; Markoulaki, S.; Jaenisch, R. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 26:916-924; 2008.
385. Wernig, M.; Meissner, A.; Cassady, J. P.; Jaenisch, R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2:10-12; 2008.
386. Wernig, M.; Meissner, A.; Foreman, R.; Brambrink, T.; Ku, M.; Hochedlinger, K.; Bernstein, B. E.; Jaenisch, R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318-324; 2007.
387. Wernig, M.; Zhao, J.; Pruszak, J.; Hedlund, E.; Fu, D.; Soldner, F. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 105:5856-5861; 2008.
388. White, R.; and Jakeman, L. Don't fence me in: Harnessing the beneficial roles of astrocytes for spinal cord repair. Restor. Neurol. Neurosci. 26:197-214; 2008.
389. Wilson, K. D.; Venkatasubrahmanyam, S.; Jia, F.; Sun, N.; Butte, A. J.; Wu, J. C. MicroRNA profiling of human- induced pluripotent stem cells. Stem Cells Dev. 18:749-757; 2009.
390. Winkler, T.; Cantilena, A.; Metais, J.-Y.; Xu, X.; Nguyen, A.-D.; Borate, B.; Antosiewicz-Bourget, J. E.; Wolfsberg, T. G.; Thomson, J. A.; Dunbar, C. E. No evidence for clonal selection due to lentiviral integration sites in human induced pluripotent stem cells. Stem Cells 28:687-694; 2010.
391. Wobus, A. M. The Janus face of pluripotent stem cells- Connection between pluripotency and tumourigenicity. Bioessays 32:993-1002; 2010.
392. Woltjen, K.; Michael, I.; Mohseni, P.; Desai, R.; Mileikovsky, M.; Hamalainen, R. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458:766-771; 2009.
393. Wong, D. J.; Liu, H.; Ridky, T. W.; Cassarino, D.; Segal, E.; Chang, H. Y. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2:333-344; 2008.
394. Wong, R. C.-B.; Donovan, P. J.; Pebay, A. Molecular mechanism involved in the maintenance of pluripotent stem cells. In: Rosales, D. W.; Mullen. Q., eds. Pluripotent Stem Cells. New York, NY: Nova Science Publisher; 2010:47-79.
395. Wu, Z.; Chen, J.; Ren, J.; Bao, L.; Liao, J.; Cui, C.; Rao, L.; Li, H.; Gu, Y.; Dai, H.; Zhu, H.; Teng, X.; Cheng, L.; Xiao, L. Generation of pig induced pluripotent stem cells with a drug- inducible system. J. Mol. Cell Biol. 1:46-54; 2009.
396. Xu, D.; Alipio, Z.; Fink, L. M.; Adcock, D. M.; Yang, J.; Ward, D. C.; Ma, Y. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc. Natl. Acad. Sci. USA 106:808-813; 2009.
397. Xu, J.; Wang, H.; Liang, T.; Cai, X.; Rao, X.; Huang, Z.; Sheng, G. In vitro induction of mouse meningeal-derived ips cells into neural-like cells. Chin. Sci. Bull. 56:1556-1561; 2011.
398. Yakubov, E.; Rechavi, G.; Rozenblatt, S.; Givol, D. Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem. Biophys. Res. Commun. 394:189-193; 2010.
399. Yamanaka, S. Elite and stochastic models for induced pluri- potent stem cell generation. Nature 460:49-52; 2009.
400. Yamanaka, S. Pluripotency and nuclear reprogramming. Philos. Trans. R. Soc. Lond. Biol. Sci. 363:2079-2087; 2008.
401. Yamanaka, S.; Blau, H. M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 465:704-712; 2010.
402. Yamashita, T.; Kawai, H.; Tian, F.; Ohta, Y.; Abe, K. Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain. Cell Transplant. 20:883-891; 2011.
403. Yan, B.; Abdelli, L. S.; Singla, D. K. Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db/db mice. Mol. Pharm. 8:1602-1610; 2011.
404. Yang, J.; Cai, J.; Zhang, Y.; Wang, X.; Li, W.; Xu, J.; Li, F.; Guo, X.; Deng, K.; Zhong, M.; Chen, Y.; Lai, L.; Pei, D.; Esteban, M. A. Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader- Willi syndrome. J. Biol. Chem. 285:40303-40311; 2010.
405. Yao, X.-L.; Liu, Q.; Ye, C.-H.; Li, Z.-P.; Lu, X.-L.; Li, P.-L.; Li, X.-B.; Li, W.-Q. Neuronal differentiation potential of mouse induced pluripotent stem cells. Neuroreport 22:689-695; 2011.
406. Ye, L.; Chang, J. C.; Lin, C.; Qi, Z.; Yu, J.; Kan, Y. W. Generation of induced pluripotent stem cells using site- specific integration with phage integrase. Proc. Natl. Acad. Sci. USA 107:19467-19472; 2010.
407. Yehezkel, S.; Rebibo-Sabbah, A.; Segev, Y.; Tzukerman, M.; Shaked, R.; Huber, I.; Gepstein, L.; Skorecki, K.; Selig, S. Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics 6:63-75; 2011.
408. Yoshida, Y.; Takahashi, K.; Okita, K.; Ichisaka, T.; Yamanaka, S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5:237-241; 2009.
409. Yu, J.; Hu, K.; Smuga-Otto, K.; Tian, S.; Stewart, R.; Slukvin, I. Human induced pluripotent stem cells free of vector and transfene sequences. Science 324:797-801; 2009.
410. Yu, J.; Vodyanik, M.; Smuga-Otto, K.; Antosiewicz- Bourget, J.; Frane, J.; Tian, S.; Nie, J.; Jonsdottir G. A.; Ruotti, V.; Stewart, R.; Slukvin, I. I.; Thomson, J. A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920; 2007.
411. Yusa, K.; Rad, R.; Takeda, J.; Bradley, A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat. Methods 6:363-369; 2009.
412. Yusa, K.; Zhou, L.; Li, M. A.; Bradley, A.; Craig, N. L. A hyperactive piggyBac transposase for mammalian applications. Proc. Natl. Acad. Sci. USA 108:1531-1536; 2011.
413. Zeng, H.; Guo, M.; Martins-Taylor, K.; Wang, X.; Zhang, Z.; Park, J. W.; Zhan, S.; Kronenberg, M. S.; Lichtler, A.; Liu, H.-X.; Chen, F.-P.; Yue, L.; Li, X.-J.; Xu, R.-H. Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluri- potent stem cells. PLoS One 5:e11853; 2010.
414. Zeuschner, D.; Mildner, K.; Zaehres, H.; Schoeler, H. R. Induced pluripotent stem cells at nanoscale. Stem Cells Dev. 19:615-620; 2010.
415. Zhang, G.; Shang, B.; Yang, P.; Cao, Z.; Pan, Y.; Zhou, Q. Induced pluripotent stem cell consensus genes: Implication for the risk of tumorigenesis and cancers in induced pluripotent stem cell therapy. Stem Cells Dev. 21:955-964; 2012.
416. Zhang, N.; An, M. C.; Montoro, D.; Ellerby, L. M. Characterization of human huntington's disease cell model from induced pluripotent stem cells. PLoS Curr. 2:RRN1193; 2010.
417. Zhang, Y. Z.; Wang, D.; Chen, M. L.; Yang, B.; Zhang, F. X.; Cao, K. J. Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigen- esis in the heart. PLoS One 6:e19012; 2011.
418. Zhang, Z.; Guth, L. Experimental spinal cord injury: Walle- rian degeneration in the dorsal column is followed by revascularization, glial proliferation, and nerve regeneration. Exp. Neurol. 147:159-171; 1997.
419. Zhao, T.; Zhang, Z.-N.; Rong, Z.; Xu, Y. Immunogenicity of induced pluripotent stem cells. Nature 474:212-215; 2011.
420. Zhao, X.-Y.; Li, W.; Lv, Z.; Liu, L.; Tong, M.; Hai, T.; Hao, J.; Guo, C.-L.; Ma, Q.-W.; Wang, L.; Zeng, F.; Zhou, Q. iPS cells produce viable mice through tetraploid complementation. Nature 461:86-90; 2009.
421. Zhao, Y.; Yin, X.; Qin, H.; Zhu, F.; Liu, H.; Yang, W.; Zhang, Q.; Xiang, C.; Hou, P.; Song, Z.; Liu, Y.; Yong, J.; Zhang, P.; Cai, J.; Liu, M.; Li, H.; Li, Y.; Qu, X.; Cui, K.; Zhang, W.; Xiang, T.; Wu, Y.; Zhao, Y.; Liu, C.; Yu, C.; Yuan, K.; Lou, J.; Ding, M.; Deng, H. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3:475-479; 2008.
422. Zhong, B.; Trobridge, G. D.; Zhang, X.; Watts, K. L.; Ramakrishnan, A.; Wohlfahrt, M.; Adair, J. E.; Kiem, H.-P. Efficient generation of nonhuman primate induced pluripotent stem cells. Stem Cells Dev. 20:795-807; 2011.
423. Zhong, B.; Watts, K. L.; Gori, J. L.; Wohlfahrt, M. E.; Enssle, J.; Adair, J. E.; Kiem, H.-P. Safeguarding nonhuman primate iPS cells with suicide genes. Mol. Ther. 19:1667-1675; 2011.
424. Zhou, H.; Wu, S.; Joo, J.; Zhu, S.; Han, D.; Lin, T. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4:381-384; 2009.
425. Zhou, J.; Su, P.; Li, D.; Tsang, S.; Duan, E.; Wang, F. High- efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor-p superfamily receptors. Stem Cells 28:1741-1750; 2010.
426. Zhou, L.; Wang, W.; Liu, Y.; de Castro, J. F.; Ezashi, T.; Telugu, B. P. V. L.; Roberts, R. M.; Kaplan, H. J.; Dean, D. C. Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina. Stem Cells 29:972-980; 2011.
427. Zhou, W.; Freed, C. R. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27:2667-2674; 2009.
428. Zhu, S.; Li, W.; Zhou, H.; Wei, W.; Ambasudhan, R.; Lin, T.; Kim, J.; Zhang, K.; Ding, S. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7:651-655; 2010.